Fibroblast growth factor 21 (FGF21) is an endocrine hormone that is primarily expressed in the liver and exerts beneficial effects on obesity and related metabolic diseases. In addition to its remarkable pharmacologic actions, the physiological roles of FGF21 include the maintenance of energy homeostasis in the body in conditions of metabolic or environmental stress. The expression of FGF21 is induced in multiple organs in response to diverse physiological or pathological stressors, such as starvation, nutrient excess, autophagy deficiency, mitochondrial stress, exercise, and cold exposure. Thus, the FGF21 induction caused by stress plays an important role in adaptive response to these stimuli. Here, we highlight our current understanding of the functional importance of the induction of FGF21 by diverse stressors as a feedback mechanism that prevents excessive stress.

Citations

Citations to this article as recorded by  

• Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network
  Shuo Li, Tiande Zou, Jun Chen, Jiaming Li, Jinming You
  Genes & Diseases.2024; 11(3): 101064.     CrossRef
• From Beats to Metabolism: the Heart at the Core of Interorgan Metabolic Cross Talk
  Rafael Romero-Becera, Ayelén M. Santamans, Alba C. Arcones, Guadalupe Sabio
  Physiology.2024; 39(2): 98.     CrossRef
• Beneficial Effects of Low-Grade Mitochondrial Stress on Metabolic Diseases and Aging
  Se Hee Min, Gil Myoung Kang, Jae Woo Park, Min-Seon Kim
  Yonsei Medical Journal.2024; 65(2): 55.     CrossRef
• GDF15 is a dynamic biomarker of the integrated stress response in the central nervous system
  Jyoti Asundi, Chunlian Zhang, Diana Donnelly‐Roberts, Josè Zavala Solorio, Malleswari Challagundla, Caitlin Connelly, Christina Boch, Jun Chen, Mario Richter, Mohammad Mehdi Maneshi, Andrew M. Swensen, Lauren Lebon, Raphael Schiffmann, Subhabrata Sanyal,
  CNS Neuroscience & Therapeutics.2024;[Epub]     CrossRef
• Deciphering adipose development: Function, differentiation and regulation
  Ge Guo, Wanli Wang, Mengjie Tu, Binbin Zhao, Jiayang Han, Jiali Li, Yanbing Pan, Jie Zhou, Wen Ma, Yi Liu, Tiantian Sun, Xu Han, Yang An
  Developmental Dynamics.2024;[Epub]     CrossRef
• Inflammatory liver diseases and susceptibility to sepsis
  Hong Lu
  Clinical Science.2024; 138(7): 435.     CrossRef
• Fibroblast growth factor 21 and bone homeostasis
  Yan Tang, Mei Zhang
  Biomedical Journal.2023; 46(4): 100548.     CrossRef
• Chronic docosahexaenoic acid supplementation improves metabolic plasticity in subcutaneous adipose tissue of aged obese female mice
  Elisa Félix-Soriano, Neira Sáinz, Marta Fernández-Galilea, Eva Gil-Iturbe, Jon Celay, José A. Martínez-Climent, María J. Moreno-Aliaga
  The Journal of Nutritional Biochemistry.2023; 111: 109153.     CrossRef
• Fibroblast Growth Factor–Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications
  Leigang Jin, Ranyao Yang, Leiluo Geng, Aimin Xu
  Annual Review of Pharmacology and Toxicology.2023; 63(1): 359.     CrossRef
• The effect of FGF21 gene polymorphism (g. 940C/T) on biochemical metabolic parameters in blood serum of holstein cattle
  N. Yu. Safina, Sh. K. Shakrov, E. R. Gaynutdinova, Z. F. Fattakhova
  International Journal of Veterinary Medicine.2023; (4): 314.     CrossRef
• Fibroblast growth factor 21 is expressed and secreted from skeletal muscle following electrical stimulation via extracellular ATP activation of the PI3K/Akt/mTOR signaling pathway
  Manuel Arias-Calderón, Mariana Casas, Julián Balanta-Melo, Camilo Morales-Jiménez, Nadia Hernández, Paola Llanos, Enrique Jaimovich, Sonja Buvinic
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Fibroblast growth factor 21 as a potential master regulator in metabolic disorders
  Aayushi Velingkar, Sugunakar Vuree, Pranav Kumar Prabhakar, Rajender Rao Kalashikam, Aparna Banerjee, Suresh Kondeti
  American Journal of Physiology-Endocrinology and Metabolism.2023; 324(5): E409.     CrossRef
• Association of NAFLD with FGF21 Polygenic Hazard Score, and Its Interaction with Protein Intake Level in Korean Adults
  Hae Jin Lee, Jinyoung Shon, Yoon Jung Park
  Nutrients.2023; 15(10): 2385.     CrossRef
• Blood and liver telomere length, mitochondrial DNA copy number, and hepatic gene expression of mitochondrial dynamics in mid-lactation cows supplemented with l-carnitine under systemic inflammation
  S. Häussler, M.H. Ghaffari, K. Seibt, H. Sadri, M. Alaedin, K. Huber, J. Frahm, S. Dänicke, H. Sauerwein
  Journal of Dairy Science.2023; 106(12): 9822.     CrossRef
• Pharmacological Effects of Fibroblast Growth Factor 21 (FGF21) оn Carbohydrate-Lipid Metabolism: Sex Dependence
  N. M. Bazhan, E. N. Makarova
  Успехи физиологических наук.2023; 54(4): 93.     CrossRef
• The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model
  Redin A. Spann, Christopher D. Morrison, Laura J. den Hartigh
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Long-Term Dietary Taurine Lowers Plasma Levels of Cholesterol and Bile Acids
  Ryoma Tagawa, Masaki Kobayashi, Misako Sakurai, Maho Yoshida, Hiroki Kaneko, Yuhei Mizunoe, Yuka Nozaki, Naoyuki Okita, Yuka Sudo, Yoshikazu Higami
  International Journal of Molecular Sciences.2022; 23(3): 1793.     CrossRef
• Endocrine Fibroblast Growth Factors in Relation to Stress Signaling
  Makoto Shimizu, Ryuichiro Sato
  Cells.2022; 11(3): 505.     CrossRef
• Histone Deacetylases as Modulators of the Crosstalk Between Skeletal Muscle and Other Organs
  Alessandra Renzini, Marco D’Onghia, Dario Coletti, Viviana Moresi
  Frontiers in Physiology.2022;[Epub]     CrossRef
• Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease
  Eunha Chang, Jae Seung Chang, In Deok Kong, Soon Koo Baik, Moon Young Kim, Kyu-Sang Park
  Gut and Liver.2022; 16(2): 171.     CrossRef
• FGF21: A Novel Regulator of Glucose and Lipid Metabolism and Whole-Body Energy Balance
  Ewa Szczepańska, Małgorzata Gietka-Czernel
  Hormone and Metabolic Research.2022; 54(04): 203.     CrossRef
• Exercise, Mitohormesis, and Mitochondrial ORF of the 12S rRNA Type-C (MOTS-c)
  Tae Kwan Yoon, Chan Hee Lee, Obin Kwon, Min-Seon Kim
  Diabetes & Metabolism Journal.2022; 46(3): 402.     CrossRef
• Counteracting health risks by Modulating Homeostatic Signaling
  Junqiang J. Tian, Mark Levy, Xuekai Zhang, Robert Sinnott, Rolando Maddela
  Pharmacological Research.2022; 182: 106281.     CrossRef
• Hesperidin abrogates bisphenol A endocrine disruption through binding with fibroblast growth factor 21 (FGF-21), α-amylase and α-glucosidase: an in silico molecular study
  P.M. Aja, J.N. Awoke, P.C. Agu, A.E. Adegboyega, E.M. Ezeh, I.O. Igwenyi, O.U. Orji, O.G. Ani, B.A. Ale, U.A. Ibiam
  Journal of Genetic Engineering and Biotechnology.2022; 20(1): 84.     CrossRef
• Circulating FGF21 vs. Stress Markers in Girls during Childhood and Adolescence, and in Their Caregivers: Intriguing Inter-Relations between Overweight/Obesity, Emotions, Behavior, and the Cared-Caregiver Relationship
  Eirini V. Christaki, Panagiota Pervanidou, Ioannis Papassotiriou, Aimilia Mantzou, Giorgos Giannakakis, Dario Boschiero, George P. Chrousos
  Children.2022; 9(6): 821.     CrossRef
• α‐Lipoic acid up‐regulates gene expression but reduces protein levels of fibroblast growth factor 21 in HepG2 cells
  Xiaochun Zhang, Yanyan Zhao, Xiangyan Liang, Lijun Zhang, Ke Li, Zhuo Sun, Yu‐Feng Zhao
  Basic & Clinical Pharmacology & Toxicology.2022; 131(4): 270.     CrossRef
• Multi-organ FGF21-FGFR1 signaling in metabolic health and disease
  Namrita Kaur, Sanskruti Ravindra Gare, Jiahan Shen, Rida Raja, Oveena Fonseka, Wei Liu
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Management of patients with neuropathic pain
  Eun Joo Choi
  Journal of the Korean Medical Association.2022; 65(8): 505.     CrossRef
• FGF21–Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity
  Leigang Jin, Leiluo Geng, Lei Ying, Lingling Shu, Kevin Ye, Ranyao Yang, Yan Liu, Yao Wang, Yin Cai, Xue Jiang, Qin Wang, Xingqun Yan, Boya Liao, Jie Liu, Fuyu Duan, Gary Sweeney, Connie Wai Hong Woo, Yu Wang, Zhengyuan Xia, Qizhou Lian, Aimin Xu
  Circulation.2022; 146(20): 1537.     CrossRef
• Performance and Metabolic, Inflammatory, and Oxidative Stress-Related Parameters in Early Lactating Dairy Cows with High and Low Hepatic FGF21 Expression
  Denise K. Gessner, Lena M. Sandrock, Erika Most, Christian Koch, Robert Ringseis, Klaus Eder
  Animals.2022; 13(1): 131.     CrossRef
• Relationship between FGF21 and drug or nondrug therapy of type 2 diabetes mellitus
  Chang Guo, Li Zhao, Yanyan Li, Xia Deng, Guoyue Yuan
  Journal of Cellular Physiology.2021; 236(1): 55.     CrossRef
• Skeletal Muscle and Bone – Emerging Targets of Fibroblast Growth Factor-21
  Hui Sun, Matthew Sherrier, Hongshuai Li
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Transthyretin contributes to insulin resistance and diminishes exercise-induced insulin sensitivity in obese mice by inhibiting AMPK activity in skeletal muscle
  Yingzi He, Ruojun Qiu, Beibei Wu, Weiwei Gui, Xihua Lin, Hong Li, Fenping Zheng
  American Journal of Physiology-Endocrinology and Metabolism.2021; 320(4): E808.     CrossRef
• Metabolic Messengers: FGF21
  Kyle H. Flippo, Matthew J. Potthoff
  Nature Metabolism.2021; 3(3): 309.     CrossRef
• Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations With Disease Characteristics, Body Composition, and Physical Functioning
  Patrick W. Gould, Babette S. Zemel, Elena G. Taratuta, Joshua F. Baker
  The Journal of Rheumatology.2021; 48(4): 504.     CrossRef
• The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation
  Zhao Yang, Katherine Roth, Manisha Agarwal, Wanqing Liu, Michael C. Petriello
  The Journal of Nutritional Biochemistry.2021; 95: 108633.     CrossRef
• Low‐Level Radiofrequency Exposure Induces Vasoconstriction in Rats
  Thi Cuc Mai, Anne Braun, Veronique Bach, Amandine Pelletier, Rene de Seze
  Bioelectromagnetics.2021; 42(6): 455.     CrossRef
• Anterograde regulation of mitochondrial genes and FGF21 signaling by hepatic LSD1
  Yang Cao, Lingyi Tang, Kang Du, Kitt Paraiso, Qiushi Sun, Zhengxia Liu, Xiaolong Ye, Yuan Fang, Fang Yuan, Hank Chen, Yumay Chen, Xiaorong Wang, Clinton Yu, Ira L. Blitz, Ping H. Wang, Lan Huang, Haibo Cheng, Xiang Lu, Ken W.Y. Cho, Marcus Seldin, Zhuyuan
  JCI Insight.2021;[Epub]     CrossRef
• Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis
  Aimin Wu, Bin Feng, Jie Yu, Lijun Yan, Lianqiang Che, Yong Zhuo, Yuheng Luo, Bing Yu, De Wu, Daiwen Chen
  Redox Biology.2021; 46: 102131.     CrossRef
• Stress-induced FGF21 and GDF15 in obesity and obesity resistance
  Susanne Keipert, Mario Ost
  Trends in Endocrinology & Metabolism.2021; 32(11): 904.     CrossRef
• Fibroblast growth factor 21 in dairy cows: current knowledge and potential relevance
  Klaus Eder, Denise K. Gessner, Robert Ringseis
  Journal of Animal Science and Biotechnology.2021;[Epub]     CrossRef
• Weight regain after bariatric surgery: Promoters and potential predictors
  Hala Mourad Demerdash
  World Journal of Meta-Analysis.2021; 9(5): 438.     CrossRef
• αKlotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats
  Paulo Giovani de Albuquerque Suassuna, Paula Marocolo Cherem, Bárbara Bruna de Castro, Edgar Maquigussa, Marco Antonio Cenedeze, Júlio Cesar Moraes Lovisi, Melani Ribeiro Custódio, Helady Sanders-Pinheiro, Rogério Baumgratz de Paula
  Experimental Biology and Medicine.2020; 245(1): 66.     CrossRef
• Effect of Fibroblast Growth Factor 21 on the Development of Atheromatous Plaque and Lipid Metabolic Profiles in an Atherosclerosis-Prone Mouse Model
  Hyo Jin Maeng, Gha Young Lee, Jae Hyun Bae, Soo Lim
  International Journal of Molecular Sciences.2020; 21(18): 6836.     CrossRef
• A Land of Controversy: Fibroblast Growth Factor-23 and Uremic Cardiac Hypertrophy
  Jing-Fu Bao, Pan-Pan Hu, Qin-Ying She, Aiqing Li
  Journal of the American Society of Nephrology.2020; 31(7): 1423.     CrossRef
• Possible associations between plasma fibroblast growth factor 21 levels and cognition in bipolar disorder
  Favour Omileke, Sayuri Ishiwata, Junko Matsuo, Fuyuko Yoshida, Shinsuke Hidese, Kotaro Hattori, Hiroshi Kunugi
  Neuropsychopharmacology Reports.2020; 40(2): 175.     CrossRef
• FGF21-protection against fructose-induced lipid accretion and oxidative stress is influenced by maternal nutrition in male progeny
  Elena Fauste, Silvia Rodrigo, Lourdes Rodríguez, Cristina Donis, Antonia García, Coral Barbas, Juan J. Álvarez-Millán, María I. Panadero, Paola Otero, Carlos Bocos
  Journal of Functional Foods.2020; 64: 103676.     CrossRef
• Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions
  Patrizia Formichi, Nastasia Cardone, Ilaria Taglia, Elena Cardaioli, Simona Salvatore, Annalisa Lo Gerfo, Costanza Simoncini, Vincenzo Montano, Gabriele Siciliano, Michelangelo Mancuso, Alessandro Malandrini, Antonio Federico, Maria Teresa Dotti
  Neurological Sciences.2020; 41(12): 3653.     CrossRef
• Novel Medicinal Mushroom Blend as a Promising Supplement in Integrative Oncology: A Multi-Tiered Study using 4T1 Triple-Negative Mouse Breast Cancer Model
  Elisa Roda, Fabrizio De Luca, Carmine Di Iorio, Daniela Ratto, Stella Siciliani, Beatrice Ferrari, Filippo Cobelli, Giuseppina Borsci, Erica Cecilia Priori, Silvia Chinosi, Andrea Ronchi, Renato Franco, Raffaele Di Francia, Massimiliano Berretta, Carlo Al
  International Journal of Molecular Sciences.2020; 21(10): 3479.     CrossRef
• High‐protein diet more effectively reduces hepatic fat than low‐protein diet despite lower autophagy and FGF21 levels
  Chenchen Xu, Mariya Markova, Nicole Seebeck, Anne Loft, Silke Hornemann, Thomas Gantert, Stefan Kabisch, Kathleen Herz, Jennifer Loske, Mario Ost, Verena Coleman, Frederick Klauschen, Anke Rosenthal, Volker Lange, Jürgen Machann, Susanne Klaus, Tilman Gru
  Liver International.2020; 40(12): 2982.     CrossRef
• Recharacterizing the Metabolic State of Energy Balance in Thrifty and Spendthrift Phenotypes
  Tim Hollstein, Alessio Basolo, Takafumi Ando, Susanne B Votruba, Mary Walter, Jonathan Krakoff, Paolo Piaggi
  The Journal of Clinical Endocrinology & Metabolism.2020; 105(5): 1375.     CrossRef
• Targeting of Secretory Proteins as a Therapeutic Strategy for Treatment of Nonalcoholic Steatohepatitis (NASH)
  Kyeongjin Kim, Kook Hwan Kim
  International Journal of Molecular Sciences.2020; 21(7): 2296.     CrossRef
• Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects
  Jae Min Cho, Eun Hee Yang, Wenying Quan, Eun Hye Nam, Hyae Gyeong Cheon
  Scientific Reports.2020;[Epub]     CrossRef
• Spontaneous ketonuria and risk of incident diabetes: a 12 year prospective study
  Gyuri Kim, Sang-Guk Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Ele Ferrannini, Yong-ho Lee, Nam H. Cho
  Diabetologia.2019; 62(5): 779.     CrossRef
• Combined docosahexaenoic acid and thyroid hormone supplementation as a protocol supporting energy supply to precondition and afford protection against metabolic stress situations
  Luis A. Videla
  IUBMB Life.2019; 71(9): 1211.     CrossRef
• Effects of exercise on brown and beige adipocytes
  Revati S. Dewal, Kristin I. Stanford
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2019; 1864(1): 71.     CrossRef
• Manipulating mtDNA in vivo reprograms metabolism via novel response mechanisms
  Diana Bahhir, Cagri Yalgin, Liina Ots, Sampsa Järvinen, Jack George, Alba Naudí, Tatjana Krama, Indrikis Krams, Mairi Tamm, Ana Andjelković, Eric Dufour, Jose M. González de Cózar, Mike Gerards, Mikael Parhiala, Reinald Pamplona, Howard T. Jacobs, Priit J
  PLOS Genetics.2019; 15(10): e1008410.     CrossRef
• The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients
  Paulina Kiluk, Anna Baran, Tomasz W. Kaminski, Magdalena Maciaszek, Iwona Flisiak
  Journal of Clinical Medicine.2019; 8(12): 2206.     CrossRef
• Docosahexaenoic acid‐thyroid hormone combined protocol as a novel approach to metabolic stress disorders: Relation to mitochondrial adaptation via liver PGC‐1α and sirtuin1 activation
  Romina Vargas, Bárbara Riquelme, Javier Fernández, Daniela Álvarez, Ignacio F. Pérez, Pamela Cornejo, Virginia Fernández, Luis A. Videla
  BioFactors.2019; 45(2): 271.     CrossRef
• Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials
  Fahim Ebrahimi, Carole Wolffenbuttel, Claudine A. Blum, Christine Baumgartner, Beat Mueller, Philipp Schuetz, Christian Meier, Marius Kraenzlin, Mirjam Christ-Crain, Matthias Johannes Betz
  European Respiratory Journal.2019; 53(2): 1800973.     CrossRef
• Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat
  Huating Li, Guangyu Wu, Qichen Fang, Mingliang Zhang, Xiaoyan Hui, Bin Sheng, Liang Wu, Yuqian Bao, Peng Li, Aimin Xu, Weiping Jia
  Nature Communications.2018;[Epub]     CrossRef
• Effects of supplementing rumen-protected niacin on fiber composition and metabolism of skeletal muscle in dairy cows during early lactation
  J.O. Zeitz, A. Weber, E. Most, W. Windisch, C. Bolduan, J. Geyer, F.-J. Romberg, C. Koch, K. Eder
  Journal of Dairy Science.2018; 101(9): 8004.     CrossRef
• The mitochondrial unfolded protein response and mitohormesis: a perspective on metabolic diseases
  Hyon-Seung Yi, Joon Young Chang, Minho Shong
  Journal of Molecular Endocrinology.2018; 61(3): R91.     CrossRef
• Berberine-induced activation of AMPK increases hepatic FGF21 expression via NUR77
  Feiye Zhou, Mengyao Bai, Yuqing Zhang, Qin Zhu, Linlin Zhang, Qi Zhang, Shushu Wang, Kecheng Zhu, Yun Liu, Xiao Wang, Libin Zhou
  Biochemical and Biophysical Research Communications.2018; 495(2): 1936.     CrossRef
• FGF21 Attenuates High-Fat Diet-Induced Cognitive Impairment via Metabolic Regulation and Anti-inflammation of Obese Mice
  Qingzhi Wang, Jing Yuan, Zhanyang Yu, Li Lin, Yinghua Jiang, Zeyuan Cao, Pengwei Zhuang, Michael J. Whalen, Bo Song, Xiao-Jie Wang, Xiaokun Li, Eng H. Lo, Yuming Xu, Xiaoying Wang
  Molecular Neurobiology.2018; 55(6): 4702.     CrossRef
• Leptin Mediates a Glucose-Fatty Acid Cycle to Maintain Glucose Homeostasis in Starvation
  Rachel J. Perry, Yongliang Wang, Gary W. Cline, Aviva Rabin-Court, Joongyu D. Song, Sylvie Dufour, Xian Man Zhang, Kitt Falk Petersen, Gerald I. Shulman
  Cell.2018; 172(1-2): 234.     CrossRef
• Improvement of Lipid and Glucose Metabolism by Capsiate in Palmitic Acid-Treated HepG2 Cells via Activation of the AMPK/SIRT1 Signaling Pathway
  Yufan Zang, Li Fan, Jihua Chen, Ruixue Huang, Hong Qin
  Journal of Agricultural and Food Chemistry.2018; 66(26): 6772.     CrossRef
• Fibroblast growth factor 21 as a biomarker for long‐term complications in organic acidemias
  F. Molema, E. H. Jacobs, W. Onkenhout, G. C. Schoonderwoerd, J. G. Langendonk, Monique Williams
  Journal of Inherited Metabolic Disease.2018; 41(6): 1179.     CrossRef
• The mitochondrial UPR: mechanisms, physiological functions and implications in ageing
  Tomer Shpilka, Cole M. Haynes
  Nature Reviews Molecular Cell Biology.2018; 19(2): 109.     CrossRef
• FGF21 Is Associated with Metabolic Effects and Treatment Response in Depressed Bipolar II Disorder Patients Treated with Valproate
  Hui Hua Chang, Po See Chen, Yung Wen Cheng, Tzu-Yun Wang, Yen Kuang Yang, Ru-Band Lu
  International Journal of Neuropsychopharmacology.2018; 21(4): 319.     CrossRef
• Circulating Fibroblast Growth Factor 21 is Associated with Subsequent Renal Injury Events in Patients Undergoing Coronary Angiography
  Cheng-Hsueh Wu, Ruey-Hsing Chou, Chin-Sung Kuo, Po-Hsun Huang, Chun-Chin Chang, Hsin-Bang Leu, Chin-Chou Huang, Jaw-Wen Chen, Shing-Jong Lin
  Scientific Reports.2018;[Epub]     CrossRef
• Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis
  Lucas D. BonDurant, Matthew J. Potthoff
  Annual Review of Nutrition.2018; 38(1): 173.     CrossRef
• Endocrine Regulator rFGF21 (Recombinant Human Fibroblast Growth Factor 21) Improves Neurological Outcomes Following Focal Ischemic Stroke of Type 2 Diabetes Mellitus Male Mice
  Yinghua Jiang, Ning Liu, Qingzhi Wang, Zhanyang Yu, Li Lin, Jing Yuan, Shuzhen Guo, Bum Ju Ahn, Xiao-Jie Wang, Xiaokun Li, Eng H. Lo, Xiaochuan Sun, Xiaoying Wang
  Stroke.2018; 49(12): 3039.     CrossRef
• Restricting branched‐chain amino acids: an approach to improve metabolic health
  Jacob G. Anderson, Kenzie Hintze, Erik D. Marchant
  The Journal of Physiology.2018; 596(13): 2469.     CrossRef
• Dietary Manipulations That Induce Ketosis Activate the HPA Axis in Male Rats and Mice: A Potential Role for Fibroblast Growth Factor-21
  Karen K Ryan, Amy E B Packard, Karlton R Larson, Jayna Stout, Sarah M Fourman, Abigail M K Thompson, Kristen Ludwick, Kirk M Habegger, Kerstin Stemmer, Nobuyuki Itoh, Diego Perez-Tilve, Matthias H Tschöp, Randy J Seeley, Yvonne M Ulrich-Lai
  Endocrinology.2018; 159(1): 400.     CrossRef
• Mitochondrial dysfunction in cancer: Potential roles of ATF5 and the mitochondrial UPR
  Pan Deng, Cole M. Haynes
  Seminars in Cancer Biology.2017; 47: 43.     CrossRef
• Modulation of energy balance by fibroblast growth factor 21
  Daniel Cuevas-Ramos, Carlos A. Aguilar-Salinas
  Hormone Molecular Biology and Clinical Investigation.2017;[Epub]     CrossRef
• Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
  Kelvin H. M. Kwok, Karen S. L. Lam
  Endocrinology and Metabolism.2017; 32(2): 145.     CrossRef
• The U-shaped relationship between fibroblast growth factor 21 and microvascular complication in type 2 diabetes mellitus
  Chan-Hee Jung, Sang-Hee Jung, Bo-Yeon Kim, Chul-Hee Kim, Sung-Koo Kang, Ji-Oh Mok
  Journal of Diabetes and its Complications.2017; 31(1): 134.     CrossRef
• A combined docosahexaenoic acid–thyroid hormone protocol upregulates rat liver β-Klotho expression and downstream components of FGF21 signaling as a potential novel approach to metabolic stress conditions
  R. Vargas, B. Riquelme, J. Fernández, L. A. Videla
  Food & Function.2017; 8(11): 3980.     CrossRef
• Anti-inflammatory effects of exercise training in adipose tissue do not require FGF21
  Jay W Porter, Joe L Rowles, Justin A Fletcher, Terese M Zidon, Nathan C Winn, Leighton T McCabe, Young-Min Park, James W Perfield, John P Thyfault, R Scott Rector, Jaume Padilla, Victoria J Vieira-Potter
  Journal of Endocrinology.2017; 235(2): 97.     CrossRef
• Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice
  Kang Ho Kim, Sungwoo Choi, Ying Zhou, Eun Young Kim, Jae Man Lee, Pradip K. Saha, Sayeepriyadarshini Anakk, David D. Moore
  Hepatology.2017; 66(2): 498.     CrossRef
• Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease
  Marina Kohara, Takahiro Masuda, Kazuhiro Shiizaki, Tetsu Akimoto, Yuko Watanabe, Sumiko Honma, Chuji Sekiguchi, Yasuharu Miyazawa, Eiji Kusano, Yoshinobu Kanda, Yasushi Asano, Makoto Kuro-o, Daisuke Nagata, Tatsuo Shimosawa
  PLOS ONE.2017; 12(6): e0178971.     CrossRef
• Analysis of hepatic transcript profile and plasma lipid profile in early lactating dairy cows fed grape seed and grape marc meal extract
  Denise K. Gessner, Anne Winkler, Christian Koch, Georg Dusel, Gerhard Liebisch, Robert Ringseis, Klaus Eder
  BMC Genomics.2017;[Epub]     CrossRef
• The FGF21-CCL11 Axis Mediates Beiging of White Adipose Tissues by Coupling Sympathetic Nervous System to Type 2 Immunity
  Zhe Huang, Ling Zhong, Jimmy Tsz Hang Lee, Jialiang Zhang, Donghai Wu, Leiluo Geng, Yu Wang, Chi-Ming Wong, Aimin Xu
  Cell Metabolism.2017; 26(3): 493.     CrossRef
• Fibroblast growth factor 21 and its novel association with oxidative stress
  Miguel Ángel Gómez-Sámano, Mariana Grajales-Gómez, Julia María Zuarth-Vázquez, Ma. Fernanda Navarro-Flores, Mayela Martínez-Saavedra, Óscar Alfredo Juárez-León, Mariana G. Morales-García, Víctor Manuel Enríquez-Estrada, Francisco J. Gómez-Pérez, Daniel Cu
  Redox Biology.2017; 11: 335.     CrossRef
• FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process
  Antero Salminen, Anu Kauppinen, Kai Kaarniranta
  Journal of Molecular Medicine.2017; 95(2): 123.     CrossRef
• The Role of Autophagy in Critical Illness-induced Liver Damage
  Steven E. Thiessen, Inge Derese, Sarah Derde, Thomas Dufour, Lies Pauwels, Youri Bekhuis, Isabel Pintelon, Wim Martinet, Greet Van den Berghe, Ilse Vanhorebeek
  Scientific Reports.2017;[Epub]     CrossRef
• Implication of hepatokines in metabolic disorders and cardiovascular diseases
  Tae Woo Jung, Hye Jin Yoo, Kyung Mook Choi
  BBA Clinical.2016; 5: 108.     CrossRef
• Upregulation of rat liver PPARα‐FGF21 signaling by a docosahexaenoic acid and thyroid hormone combined protocol
  Luis A. Videla, Virginia Fernández, Romina Vargas, Pamela Cornejo, Gladys Tapia, Nelson Varela, Rodrigo Valenzuela, Allan Arenas, Javier Fernández, María C. Hernández‐Rodas, Bárbara Riquelme
  BioFactors.2016; 42(6): 638.     CrossRef
• Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk
  Leigang Jin, Zhuofeng Lin, Aimin Xu
  Diabetes & Metabolism Journal.2016; 40(1): 22.     CrossRef
• Hepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in Mice
  Panos Ziros, Zoi Zagoriti, George Lagoumintzis, Venetsana Kyriazopoulou, Ralitsa P. Iskrenova, Evagelia I. Habeos, Gerasimos P. Sykiotis, Dionysios V. Chartoumpekis, Ioannis G Habeos, Kostas Pantopoulos
  PLOS ONE.2016; 11(9): e0162024.     CrossRef
• Metabolic fibroblast growth factors (FGFs): Mediators of energy homeostasis
  Kathleen R. Markan, Matthew J. Potthoff
  Seminars in Cell & Developmental Biology.2016; 53: 85.     CrossRef
• miR‐212 downregulation contributes to the protective effect of exercise against non‐alcoholic fatty liver via targeting FGF‐21
  Junjie Xiao, Yihua Bei, Jingqi Liu, Jasmina Dimitrova‐Shumkovska, Dapeng Kuang, Qiulian Zhou, Jin Li, Yanning Yang, Yang Xiang, Fei Wang, Changqing Yang, Wenzhuo Yang
  Journal of Cellular and Molecular Medicine.2016; 20(2): 204.     CrossRef
• Fibroblast growth factor 21 and exercise-induced hepatic mitochondrial adaptations
  Justin A. Fletcher, Melissa A. Linden, Ryan D. Sheldon, Grace M. Meers, E. Matthew Morris, Anthony Butterfield, James W. Perfield, John P. Thyfault, R. Scott Rector
  American Journal of Physiology-Gastrointestinal and Liver Physiology.2016; 310(10): G832.     CrossRef
• New adipokines
  Bruno Fève, Claire Bastard, Soraya Fellahi, Jean-Philippe Bastard, Jacqueline Capeau
  Annales d'Endocrinologie.2016; 77(1): 49.     CrossRef
• Stress Signaling Between Organs in Metazoa
  Edward Owusu-Ansah, Norbert Perrimon
  Annual Review of Cell and Developmental Biology.2015; 31(1): 497.     CrossRef
• Dietary restriction in obese children and its relation with eating behavior, fibroblast growth factor 21 and leptin: a prospective clinical intervention study
  Lorena del Rocío Ibarra-Reynoso, Liudmila Pisarchyk, Elva Leticia Pérez-Luque, Ma. Eugenia Garay-Sevilla, Juan Manuel Malacara
  Nutrition & Metabolism.2015;[Epub]     CrossRef
• FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs
  Kook Hwan Kim, Myung-Shik Lee
  Journal of Endocrinology.2015; 226(1): R1.     CrossRef
• Effects of a plant product consisting of green tea and curcuma extract on milk production and the expression of hepatic genes involved in endoplasmic stress response and inflammation in dairy cows
  Anne Winkler, Denise K. Gessner, Christian Koch, Franz-Josef Romberg, Georg Dusel, Eva Herzog, Erika Most, Klaus Eder
  Archives of Animal Nutrition.2015; 69(6): 425.     CrossRef
• The effect of grape seed and grape marc meal extract on milk performance and the expression of genes of endoplasmic reticulum stress and inflammation in the liver of dairy cows in early lactation
  D.K. Gessner, C. Koch, F.-J. Romberg, A. Winkler, G. Dusel, E. Herzog, E. Most, K. Eder
  Journal of Dairy Science.2015; 98(12): 8856.     CrossRef
• Vascular protection with fibroblast growth factor 21 in diabetes: Its potential beyond glucose and lipid control
  Mi-Hua Liu
  International Journal of Cardiology.2015; 199: 403.     CrossRef

With worldwide epidemic of diabetes mellitus, diabetic nephropathy which is one of the major causes of microvascular complication has become a serious concern in Korea as well as the rest of the world. In view of its significance, there is an urgent and paramount need for proper managements that could either deter or slow the progression of diabetic nephropathy. Despite advances in care, ever increasing number of patients suffering from diabetic kidney disease and from end-stage renal disease implies that the current management is not adequate in many aspects. The reasons for these inadequacies compromise lack of early diagnosis, failure to intervene with timely and aggressive manner, and lack of understanding on the kind of interventions required. Another issue equally important for the adequate care of patients with diabetic nephropathy is an understanding of past, present and future epidemiology of diabetic nephropathy which serves, especially in Korea, as a material determining standard diagnosis and treatment and a national health-policy decision.

Citations

Citations to this article as recorded by  

• N6-methyladenosine RNA methylation in diabetic kidney disease
  Jiaan Huang, Fan Yang, Yan Liu, Yuehua Wang
  Biomedicine & Pharmacotherapy.2024; 171: 116185.     CrossRef
• Association of advanced chronic kidney disease with diabetic retinopathy severity in older patients with diabetes: a retrospective cross-sectional study
  Geun Woo Lee, Chul Ho Lee, Seong Gyu Kim
  Journal of Yeungnam Medical Science.2023; 40(2): 146.     CrossRef
• Age at Mortality in Patients with Type 2 Diabetes Who Underwent Kidney Transplantation: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
  Sun Ok Song, Eugene Han, Kang Ju Son, Bong-Soo Cha, Byung-Wan Lee
  Journal of Clinical Medicine.2023; 12(9): 3160.     CrossRef
• Single‐cell RNA‐seq with spatial transcriptomics to create an atlas of human diabetic kidney disease
  Duo Chen, Mingwei Shao, Yi Song, Gaofei Ren, Feng Guo, Xunjie Fan, Yanyan Wang, Wei Zhang, Guijun Qin
  The FASEB Journal.2023;[Epub]     CrossRef
• Metabolomic profiling of amino acids study reveals a distinct diagnostic model for diabetic kidney disease
  Jiao Wang, Chunyu Zhou, Qing Zhang, Zhangsuo Liu
  Amino Acids.2023; 55(11): 1563.     CrossRef
• New insights into the mechanisms of diabetic kidney disease: Role of circadian rhythm and Bmal1
  Zhimei Peng, Yanting Liang, Xueying Liu, Jie Shao, Nan Hu, Xinzhou Zhang
  Biomedicine & Pharmacotherapy.2023; 166: 115422.     CrossRef
• Physical exercise as a friend not a foe in acute kidney diseases through immune system modulation
  Ana Carolina Costanti-Nascimento, Leonilia Brelaz-Abreu, Elayne Bragança-Jardim, Welbert de Oliveira Pereira, Niels Olsen Saraiva Camara, Mariane Tami Amano
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trial
  Li Zhang, Tongdan Wang, Yan Kong, Haizhen Sun, Yuling Zhang, Junmei Wang, Zhida Wang, Shan Lu, Pei Yu, Saijun Zhou
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• Neutrophil lymphocyte ratio: a reliable biomarker for diabetic nephropathy?
  Ashutosh Singh, Anshu Kumar Jha, Bipul Chandra Kalita, Dharmendra Kumar Jha, Yash Alok
  International Journal of Diabetes in Developing Countries.2022; 42(3): 523.     CrossRef
• miR-193a as a potential mediator of WT-1/synaptopodin in the renoprotective effect of Losartan on diabetic kidney
  Dan Gao, Pei Yu, Sanhui Jing, Chengcheng Yan, Dandan Ding, Yingjin Qiao, Ge Wu
  Canadian Journal of Physiology and Pharmacology.2022; 100(1): 26.     CrossRef
• 3-Hydroxybutyrate Ameliorates the Progression of Diabetic Nephropathy
  Jeeyoun Jung, Woo Yeong Park, Yun Jin Kim, Mikyung Kim, Misun Choe, Kyubok Jin, Ji Hae Seo, Eunyoung Ha
  Antioxidants.2022; 11(2): 381.     CrossRef
• Emerging Role of Epitranscriptomics in Diabetes Mellitus and Its Complications
  Xinqian Geng, Zheng Li, Ying Yang
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Analysis of serum circulating MicroRNAs level in Malaysian patients with gestational diabetes mellitus
  Sajad Jamalpour, Shamsul Mohd Zain, Reza Vazifehmand, Zahurin Mohamed, Yuh Fen Pung, Hesam Kamyab, Siti Zawiah Omar
  Scientific Reports.2022;[Epub]     CrossRef
• Combined Single-Cell RNA-Seq and Spatial Transcriptomics Reveal an Atlas of Human Diabetic Kidney Disease
  Duo Chen, Mingwei Shao, Yi Song, Gaofei Ren, Feng Guo, Xunjie Fan, Yanyan Wang, Wei Zhang, Guijun Qin
  SSRN Electronic Journal .2022;[Epub]     CrossRef
• How to inhibit transforming growth factor beta safely in diabetic kidney disease
  Yuxin Yang, Kexin Shi, Devang M. Patel, Fang Liu, Tieqiao Wu, Zhonglin Chai
  Current Opinion in Nephrology & Hypertension.2021; 30(1): 115.     CrossRef
• Plasma miR-193a-3p can be a potential biomarker for the diagnosis of diabetic nephropathy
  Yan Hong, Jidong Wang, Lai Zhang, Wenjuan Sun, Xuefang Xu, Kaiyue Zhang
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.2021; 58(2): 141.     CrossRef
• Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes
  Jae-Seung Yun, Yong-Moon Park, Kyungdo Han, Hyung-Wook Kim, Seon-Ah Cha, Yu-Bae Ahn, Seung-Hyun Ko
  Scientific Reports.2021;[Epub]     CrossRef
• Integrin β3 overexpression contributes to podocyte injury through inhibiting RhoA/YAP signaling pathway
  Zhuo Li, Zhiwen Lian, Jianchao Ma, Li Zhang, Xingji Lian, Shuangxin Liu, Jianteng Xie, Zhonglin Feng, Ting Lin, Hong Zhang, Xinling Liang
  Bioengineered.2021; 12(1): 1138.     CrossRef
• A Nonlinear Relationship Between Serum 25-Hydroxyvitamin D and Urine Albumin to Creatinine Ratio in Type 2 Diabetes: A Cross-Sectional Study in China
  Qian Liang, Haofei Hu, Han Wu, Xuan Chen, Wei Wang, Ying Le, Shufen Yang, Lijing Jia
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 2581.     CrossRef
• Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetes
  Young-eun Kim, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-soo Cha, Byung-Wan Lee
  Diabetes Research and Clinical Practice.2021; 181: 109082.     CrossRef
• USP9X prevents AGEs-induced upregulation of FN and TGF-β1 through activating Nrf2-ARE pathway in rat glomerular mesangial cells
  Kaipeng Huang, Xilin Zhao
  Experimental Cell Research.2020; 393(2): 112100.     CrossRef
• D-dimer Levels in Chronic Kidney Illness: A Comprehensive and Systematic Literature Review
  Sahar Vahdat, Shahrzad Shahidi
  Proceedings of the National Academy of Sciences, India Section B: Biological Sciences.2020; 90(5): 911.     CrossRef
• Circulating Expression Level of LncRNA Malat1 in Diabetic Kidney Disease Patients and Its Clinical Significance
  Lian-ji Zhou, Da-wei Yang, Li-Na Ou, Xing-Rong Guo, Biao-liang Wu
  Journal of Diabetes Research.2020; 2020: 1.     CrossRef
• Impact of chronic kidney disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 diabetes in the UK: A cohort study using primary care data from the United Kingdom
  Antonio González-Pérez, Maria E. Saéz, David Vizcaya, Marcus Lind, Luis A. García Rodríguez
  Primary Care Diabetes.2020; 14(4): 381.     CrossRef

• Resveratrol Inhibits Lipopolysaccharide-Induced Extracellular Matrix Accumulation and Inflammation in Rat Glomerular Mesangial Cells by SphK1/S1P2/NF-κB Pathway

  
  Wenyan Gong, Jie Li, Wenying Chen, Fuzhen Feng, Yanhui Deng
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 4495.     CrossRef
• Effects of dietary iron restriction on kidney mitochondria function and oxidative stress in streptozotocin-diabetic rats
  Donovan J. Peña-Montes, Maribel Huerta-Cervantes, Mónica Ríos-Silva, Xóchitl Trujillo, Christian Cortés-Rojo, Miguel Huerta, Alfredo Saavedra-Molina
  Mitochondrion.2020; 54: 41.     CrossRef
• Significance of glycated LDL in different stages of diabetic nephropathy
  Khalid Siddiqui, Teena P. George, Shaik Sarfaraz Nawaz, Maram Yaslam, Ebtehal Almogbel, Khalid Al-Rubeaan
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(1): 548.     CrossRef
• Prognostic value of visit-to-visit systolic blood pressure variability related to diabetic kidney disease among patients with type 2 diabetes
  Zhe-Bin Yu, Jian-Bing Wang, Die Li, Xue-Yu Chen, Hong-Bo Lin, Kun Chen
  Journal of Hypertension.2019; 37(7): 1411.     CrossRef
• Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
  Mitsuo Kato, Rama Natarajan
  Nature Reviews Nephrology.2019; 15(6): 327.     CrossRef
• Resveratrol inhibits high glucose-induced activation of AP-1 and NF-κB via SphK1/S1P2 pathway to attenuate mesangial cells proliferation and inflammation
  Yanhui Deng, Wenyan Gong, Qiang Li, Xian Wu, Liyao Wu, Xiaoxia Zheng, Wenying Chen, Heqing Huang
  Journal of Functional Foods.2019; 55: 86.     CrossRef
• Predictive Factors for Efficacy of AST-120 Treatment in Diabetic Nephropathy: a Prospective Single-Arm, Open-Label, Multi-Center Study
  You-Cheol Hwang, Se Won Kim, Kyu Yeon Hur, Bong-Soo Cha, In Joo Kim, Tae Sun Park, Sei Hyun Baik, Kun Ho Yoon, Kwan Woo Lee, In Kyu Lee, Moon-Kyu Lee
  Journal of Korean Medical Science.2019;[Epub]     CrossRef
• Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes
  Hoyoon Lee, Wonwhi Na, Sang Bae Lee, Chul Woo Ahn, Jun Sung Moon, Kyu Chang Won, Sehyun Shin
  Frontiers in Physiology.2019;[Epub]     CrossRef
• Comparing the Effect of Dipeptidyl-Peptidase 4 Inhibitors and Sulfonylureas on Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Prospective Open-Label Study
  Po-Chung Cheng, Shang-Ren Hsu, Jeng-Fu Kuo, Yun-Chung Cheng, Yu-Hsiu Liu, Shih-Te Tu
  Journal of Clinical Medicine.2019; 8(10): 1715.     CrossRef
• Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease
  Yaeni Kim, Cheol Whee Park
  International Journal of Molecular Sciences.2019; 20(7): 1782.     CrossRef
• Regulatory T cells in acute and chronic kidney diseases
  Rahul Sharma, Gilbert R. Kinsey
  American Journal of Physiology-Renal Physiology.2018; 314(5): F679.     CrossRef
• Herba Artemisiae Capillaris Extract Prevents the Development of Streptozotocin-Induced Diabetic Nephropathy of Rat
  Jianan Geng, Xiaoyan Yu, Chunyu Liu, Chengbo Sun, Menghuan Guo, Zhen Li, Yingli Jin, Yinggang Zou, Jinghua Yu
  Evidence-Based Complementary and Alternative Medicine.2018; 2018: 1.     CrossRef
• Overview of the burden of illness and the role of once-weekly glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes
  Deborah Hinnen
  Journal of the American Association of Nurse Practitioners.2018; 30(1): S4.     CrossRef
• Previous Exercise Training Reduces Markers of Renal Oxidative Stress and Inflammation in Streptozotocin-Induced Diabetic Female Rats
  Liliany Souza de Brito Amaral, Cláudia Silva Souza, Rildo Aparecido Volpini, Maria Heloisa Massola Shimizu, Ana Carolina de Bragança, Daniele Canale, Antonio Carlos Seguro, Terezila Machado Coimbra, Amélia Cristina Mendes de Magalhães, Telma de Jesus Soar
  Journal of Diabetes Research.2018; 2018: 1.     CrossRef
• Critical Shear Stress is Associated with Diabetic Kidney Disease in Patients with Type 2 Diabetes
  Seung Min Chung, Jung Hyun Oh, Jun Sung Moon, Yu Kyung Kim, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
  Scientific Reports.2018;[Epub]     CrossRef
• Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia
  Yufeng Yao, Yong Li, Xiaofei Zeng, Zheng Ye, Xia Li, Lu Zhang
  Frontiers in Pharmacology.2018;[Epub]     CrossRef
• Association between poor psychosocial conditions and diabetic nephropathy in Japanese type 2 diabetes patients: A cross‐sectional study
  Hiroyo Ninomiya, Naoto Katakami, Taka‐aki Matsuoka, Mitsuyoshi Takahara, Hitoshi Nishizawa, Norikazu Maeda, Michio Otsuki, Akihisa Imagawa, Hiroyasu Iso, Tetsuya Ohira, Iichiro Shimomura
  Journal of Diabetes Investigation.2018; 9(1): 162.     CrossRef
• Urinary Microvesicle-Bound Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease
  Neng-jun Lou, Yi-hong Ni, Hong-ying Jia, Jing-ti Deng, Lu Jiang, Feng-jie Zheng, Ai-li Sun
  Journal of Diabetes Research.2017; 2017: 1.     CrossRef
• Renoprotective effect of fucoidan from Acaudina molpadioides in streptozotocin/high fat diet-induced type 2 diabetic mice
  Shiwei Hu, Jinhui Wang, Jingfeng Wang, Shijie Li, Wei Jiang, Yu Liu
  Journal of Functional Foods.2017; 31: 123.     CrossRef
• Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea
  Y. J. Jeong, H. Kim, S. J. Baik, T. M. Kim, S. J. Yang, S.-H. Lee, J.-H. Cho, H. Lee, H. W. Yim, I. Y. Choi, K.-H. Yoon, H.-S. Kim
  Journal of Clinical Pharmacy and Therapeutics.2017; 42(3): 292.     CrossRef
• Visualization of kidney fibrosis in diabetic nephropathy by long diffusion tensor imaging MRI with spin-echo sequence
  Jun-Ya Kaimori, Yoshitaka Isaka, Masaki Hatanaka, Satoko Yamamoto, Naotsugu Ichimaru, Akihiko Fujikawa, Hiroshi Shibata, Akira Fujimori, Sosuke Miyoshi, Takashi Yokawa, Kagayaki Kuroda, Toshiki Moriyama, Hiromi Rakugi, Shiro Takahara
  Scientific Reports.2017;[Epub]     CrossRef
• Rutin suppresses high glucose-induced ACTA2 and p38 protein expression in diabetic nephropathy
  Chun-Shan Han, Kai Liu, Ning Zhang, Shi-Wen Li, Hai-Cheng Gao
  Experimental and Therapeutic Medicine.2017; 14(1): 181.     CrossRef
• Emodin self-emulsifying platform ameliorates the expression of FN, ICAM-1 and TGF-β1 in AGEs-induced glomerular mesangial cells by promoting absorption
  Jiani Huang, Wenyan Gong, Zhiquan Chen, Junying Huang, Qiuhong Chen, Heqing Huang, Chunshun Zhao
  European Journal of Pharmaceutical Sciences.2017; 99: 128.     CrossRef
• New therapeutic agents in diabetic nephropathy
  Yaeni Kim, Cheol Whee Park
  The Korean Journal of Internal Medicine.2017; 32(1): 11.     CrossRef
• Urine clusterin/apolipoprotein J is linked to tubular damage and renal outcomes in patients with type 2 diabetes mellitus
  Sang Soo Kim, Sang Heon Song, Jong Ho Kim, Yun Kyung Jeon, Bo Hyun Kim, Min‐Cheol Kang, Sung Wan Chun, Soo Hyun Hong, Michelle Chung, Yong Ki Kim, In Joo Kim, Young‐Bum Kim
  Clinical Endocrinology.2017; 87(2): 156.     CrossRef
• Treatment of diabetic kidney disease: current and future targets
  Mi-Kyung Kim
  The Korean Journal of Internal Medicine.2017; 32(4): 622.     CrossRef
• Sphingosine kinase 1 mediates AGEs-induced fibronectin upregulation in diabetic nephropathy
  Cheng Chen, Wenyan Gong, Changzheng Li, Fengxiao Xiong, Shaogui Wang, Junying Huang, Yu Wang, Zhiquan Chen, Qiuhong Chen, Peiqing Liu, Tian Lan, Heqing Huang
  Oncotarget.2017; 8(45): 78660.     CrossRef
• Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
  Eugene Han, Gyuri Kim, Ji-Yeon Lee, Yong-ho Lee, Beom Seok Kim, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
  Endocrinology and Metabolism.2017; 32(2): 274.     CrossRef
• Glycemic Management of Patients Undergoing Dialysis
  Mi-Kyung Kim
  The Journal of Korean Diabetes.2016; 17(3): 164.     CrossRef
• Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin–Angiotensin System Blockade
  Sang-Man Jin, Kyung Ah Han, Jae Myung Yu, Tae Seo Sohn, Sung Hee Choi, Choon Hee Chung, Ie Byung Park, Eun Jung Rhee, Sei Hyun Baik, Tae Sun Park, In-Kyu Lee, Seung-Hyun Ko, You-Cheol Hwang, Bong Soo Cha, Hyoung Woo Lee, Moon-Suk Nam, Moon-Kyu Lee
  Arteriosclerosis, Thrombosis, and Vascular Biology.2016; 36(10): 2108.     CrossRef
• MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy
  Xiaoyan Hou, Jianwei Tian, Jian Geng, Xiao Li, Xun Tang, Jun Zhang, Xiaoyan Bai
  Oncotarget.2016; 7(30): 47760.     CrossRef
• Lipoprotein(a) predicts a new onset of chronic kidney disease in people with Type 2 diabetes mellitus
  J.‐S. Yun, Y.‐B. Ahn, K.‐H. Song, K.‐D. Yoo, Y.‐M. Park, H.‐W. Kim, S.‐H. Ko
  Diabetic Medicine.2016; 33(5): 639.     CrossRef
• Metabolic biomarkers for chronic kidney disease
  Marc Breit, Klaus M. Weinberger
  Archives of Biochemistry and Biophysics.2016; 589: 62.     CrossRef
• Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
  Seok Joon Shin, Sungjin Chung, Soo Jung Kim, Eun-Mi Lee, Young-Hye Yoo, Ji-Won Kim, Yu-Bae Ahn, Eun-Sook Kim, Sung-Dae Moon, Myung-Jun Kim, Seung-Hyun Ko, Kwang-Hyun Baek
  PLOS ONE.2016; 11(11): e0165703.     CrossRef
• Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice
  Gwon-Soo Jung, Jae-Han Jeon, Mi Sun Choe, Sung-Woo Kim, In-Kyu Lee, Mi-Kyung Kim, Keun-Gyu Park
  Diabetes & Metabolism Journal.2016; 40(3): 211.     CrossRef
• Beneficial effects of previous exercise training on renal changes in streptozotocin-induced diabetic female rats
  Liliany S de Brito Amaral, Fernanda A Silva, Vicente B Correia, Clara EF Andrade, Bárbara A Dutra, Márcio V Oliveira, Amélia CM de Magalhães, Rildo A Volpini, Antonio C Seguro, Terezila M Coimbra, Telma de J Soares
  Experimental Biology and Medicine.2016; 241(4): 437.     CrossRef
• Adenosine monophosphate–activated protein kinase in diabetic nephropathy
  Yaeni Kim, Cheol Whee Park
  Kidney Research and Clinical Practice.2016; 35(2): 69.     CrossRef
• Estimated Glucose Disposal Rate (eGDR) – A Marker for the Assessment of Insulin Resistance in Type 1 Diabetes Mellitus
  Mihaela L. Bîcu, Daniel Bîcu, Sigina Gârgavu, Magdalena Sandu, Mihaela I. Vladu, Diana Clenciu, Eugen Moţa, Maria Moţa
  Romanian Journal of Diabetes Nutrition and Metabolic Diseases.2016; 23(2): 177.     CrossRef
• Polydatin attenuates AGEs-induced upregulation of fibronectin and ICAM-1 in rat glomerular mesangial cells and db/db diabetic mice kidneys by inhibiting the activation of the SphK1-S1P signaling pathway
  Cheng Chen, Kaipeng Huang, Jie Hao, Junying Huang, Zhiying Yang, Fengxiao Xiong, Peiqing Liu, Heqing Huang
  Molecular and Cellular Endocrinology.2016; 427: 45.     CrossRef
• Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes
  Hye-jin Yoon, Yong-ho Lee, So Ra Kim, Tyler Hyungtaek Rim, Eun Young Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
  Cardiovascular Diabetology.2015;[Epub]     CrossRef
• Tripterygium Glycosides Tablet Ameliorates Renal Tubulointerstitial Fibrosis via the Toll-Like Receptor 4/Nuclear Factor Kappa B Signaling Pathway in High-Fat Diet Fed and Streptozotocin-Induced Diabetic Rats
  Ze-jun Ma, Xiao-na Zhang, Li Li, Wei Yang, Shan-shan Wang, Xin Guo, Pei Sun, Li-ming Chen
  Journal of Diabetes Research.2015; 2015: 1.     CrossRef
• The association between abnormal heart rate variability and new onset of chronic kidney disease in patients with type 2 diabetes: A ten-year follow-up study
  Jae-Seung Yun, Yu-Bae Ahn, Ki-Ho Song, Ki-Dong Yoo, Hyung-Wook Kim, Yong-Moon Park, Seung-Hyun Ko
  Diabetes Research and Clinical Practice.2015; 108(1): 31.     CrossRef
• Finerenone: third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease
  Licette CY Liu, Elise Schutte, Ron T Gansevoort, Peter van der Meer, Adriaan A Voors
  Expert Opinion on Investigational Drugs.2015; 24(8): 1123.     CrossRef
• Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study
  Seung Jin Han, Hae Jin Kim, Dae Jung Kim, Seung Soo Sheen, Choon Hee Chung, Chul Woo Ahn, Se Hwa Kim, Yong-Wook Cho, Seok Won Park, Soo-Kyung Kim, Chul Sik Kim, Kyung Wook Kim, Kwan Woo Lee
  Diabetology & Metabolic Syndrome.2015;[Epub]     CrossRef
• Proteomic Profile in Glomeruli of Type-2 Diabetic KKAy Mice using 2-Dimensional Differential Gel Electrophoresis
  Lining Wang
  Medical Science Monitor.2014; 20: 2705.     CrossRef

Type 2 diabetes mellitus (T2DM) is a complex endocrine and metabolic disorder, and a major public health problem that is rapidly increasing in prevalence. Although a wide range of pharmacotherapies for glycemic control is now available, management of T2DM remains complex and challenging. The kidneys contribute immensely to glucose homeostasis by reabsorbing glucose from the glomerular filtrate. Sodium-glucose cotransporter 2 (SGLT2) inhibitors, a new class of antidiabetic agents that inhibit glucose absorption from the kidney independent of insulin, offer a unique opportunity to improve the outcomes of patients with T2DM. In this review, we provide an overview of two globally-approved SGLT2 inhibitors, dapagliflozin and canagliflozin, and discuss their effects and safety. This information will help clinicians to decide whether these drugs will benefit their patients.

Citations

Citations to this article as recorded by  

• Clinical outcomes with the use of sodium-glucose cotransporter-2 inhibitors in patients with atrial fibrillation and type 2 diabetes mellitus: a multi-centre, real-world cohort study
  Jaehyuk Jang, Soyoon Park, Soohyun Kim, Sung-Hwan Kim, Yong-Seog Oh, Young Kyoung Sa, Youmi Hwang, Sung-Won Jang, Sang-Hyun Ihm, Young Choi
  European Journal of Preventive Cardiology.2024; 31(3): 320.     CrossRef
• Quantitative analysis of low-content impurity crystal forms in canagliflozin tablets by NIR solid-state analysis technique
  Mingdi Liu, Jichao Liu, Qiuhong Wang, Ping Song, Haichao Li, Zan Sun, Chenglong Shi, Weibing Dong
  Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2024; 311: 124000.     CrossRef
• A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin
  Pablo Lapuerta, Silvia Urbina, Jiaojuan He, Alyssa Wittle, Chenghai Li, Tong Li, Helen Wang, Marcus Hompesch
  Clinical Pharmacology & Therapeutics.2024;[Epub]     CrossRef
• Canagliflozin independently reduced plasma volume from conventional diuretics in patients with type 2 diabetes and chronic heart failure: a subanalysis of the CANDLE trial
  Kazuki Shiina, Hirofumi Tomiyama, Atsushi Tanaka, Takumi Imai, Itaru Hisauchi, Isao Taguchi, Akira Sezai, Shigeru Toyoda, Kaoru Dohi, Haruo Kamiya, Keisuke Kida, Toshihisa Anzai, Taishiro Chikamori, Koichi Node, Masayoshi Ajioka, Junya Ako, Rie Amano, Mit
  Hypertension Research.2023; 46(2): 495.     CrossRef
• Ecofriendly appraisal of stability‐indicating high‐performance chromatographic assay of canagliflozin and metformin with their toxic impurities; in silico toxicity prediction
  Raghda A. Emam, Aml A. Emam
  Journal of Separation Science.2023;[Epub]     CrossRef
• Effect of sodium‐glucose cotransporter 2 inhibitors on the rate of decline in kidney function: A systematic review and meta‐analysis
  Yanbei Duo, Junxiang Gao, Tao Yuan, Weigang Zhao
  Journal of Diabetes.2023; 15(1): 58.     CrossRef
• Quantitative analysis of low content polymorphic impurities in canagliflozin tablets by PXRD, NIR, ATR-FITR and Raman solid-state analysis techniques combined with stoichiometry
  Mingdi Liu, Jichao Liu, Qiuhong Wang, Ping Song, Haichao Li, Songgu Wu, Junbo Gong
  Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2023; 293: 122458.     CrossRef
• SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain
  Bartosz Rolek, Mateusz Haber, Magdalena Gajewska, Sylwester Rogula, Arkadiusz Pietrasik, Aleksandra Gąsecka
  Journal of Cardiovascular Development and Disease.2023; 10(8): 322.     CrossRef
• Cardiorenal Protections of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes
  Somayeh Nazari, Hossein Mirkhani
  Current Diabetes Reviews.2023;[Epub]     CrossRef
• Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extensio
  Jun Sung Moon, Il Rae Park, Hae Jin Kim, Choon Hee Chung, Kyu Chang Won, Kyung Ah Han, Cheol-Young Park, Jong Chul Won, Dong Jun Kim, Gwan Pyo Koh, Eun Sook Kim, Jae Myung Yu, Eun-Gyoung Hong, Chang Beom Lee, Kun-Ho Yoon
  Diabetes & Metabolism Journal.2023; 47(6): 808.     CrossRef
• Novel perspective on cardiovascular adverse event profiles due to treatment with sodium-glucose transport protein 2 (SGLT2) inhibitors in the Japanese Adverse Drug Event Report (JADER) database
  Koji Suematsu
  Personalized Medicine Universe.2023; 12: 23.     CrossRef
• The fate of flavonoids after oral administration: a comprehensive overview of its bioavailability
  Abid Naeem, Yang Ming, Hu Pengyi, Kang Yong Jie, Liu Yali, Zhang Haiyan, Xiao Shuai, Li Wenjing, Wu Ling, Zhang Ming Xia, Liu Shan Shan, Zheng Qin
  Critical Reviews in Food Science and Nutrition.2022; 62(22): 6169.     CrossRef
• Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes
  Derun Taner Ertugrul, Erdal Kan, Cigdem Bahadir Tura, Haci Bayram Tugtekin, Hayati Ayakta, Mehmet Celebioglu, Ceren Yılmaz, Onur Utebay, Ilhan Yetkin, Eren Gurkan, Kerem Sezer, Ramazan Gen, Suleyman Ozcaylak, Yildiz Okuturlar, Mehmet Coskun, Nilgun Govec
  International Journal of Diabetes in Developing Countries.2022; 42(1): 147.     CrossRef
• Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real‐world clinical practice in Korea: A national observational cohort study
  Kyoung Hwa Ha, Dae Jung Kim, Yong Jun Choi
  Journal of Diabetes Investigation.2022; 13(6): 986.     CrossRef
• Luseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function
  Yuki Yamauchi, Akinobu Nakamura, Takashi Yokota, Kiyohiko Takahashi, Shinichiro Kawata, Kazuhisa Tsuchida, Kazuno Omori, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Toshihisa Anzai, Shinya Tanaka, Yasuo Terauchi, Hideaki Miyoshi, Tatsuya Atsumi
  Scientific Reports.2022;[Epub]     CrossRef
• Blood glucose levels and bodyweight change after dapagliflozin administration
  Hyunah Kim, Seung‐Hwan Lee, Hyunyong Lee, Hyeon Woo Yim, Jae‐Hyoung Cho, Kun‐Ho Yoon, Hun‐Sung Kim
  Journal of Diabetes Investigation.2021; 12(9): 1594.     CrossRef
• Dapagliflozin Improves Cardiac Hemodynamics and Mitigates Arrhythmogenesis in Mitral Regurgitation‐Induced Myocardial Dysfunction
  Yu‐Wen Lin, Chin‐Yu Chen, Jhih‐Yuan Shih, Bor‐Chih Cheng, Ching‐Ping Chang, Mao‐Tsun Lin, Chung‐Han Ho, Zhih‐Cherng Chen, Sudeshna Fisch, Wei‐Ting Chang
  Journal of the American Heart Association.2021;[Epub]     CrossRef
• Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus
  Ja Young Jeon, Kyoung Hwa Ha, Dae Jung Kim
  Diabetes & Metabolism Journal.2021; 45(4): 505.     CrossRef
• Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway
  Ji-Yeon Lee, Minyoung Lee, Ji Young Lee, Jaehyun Bae, Eugene Shin, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
  Diabetes & Metabolism Journal.2021; 45(6): 921.     CrossRef
• SGLT2i: beyond the glucose-lowering effect
  Lihua Ni, Cheng Yuan, Guopeng Chen, Changjiang Zhang, Xiaoyan Wu
  Cardiovascular Diabetology.2020;[Epub]     CrossRef
• Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
  Eugene Han, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
  Journal of Clinical Medicine.2020; 9(1): 259.     CrossRef
• Stability Indicating, pH and pKa Dependent HPLC–DAD Method for the Simultaneous Determination of Weakly Ionizable Empagliflozin, Dapagliflozin and Canagliflozin in Pharmaceutical Formulations
  Shahzad Sharif, Rashida Bashir, Ahmad Adnan, Sabiha Mansoor, Izaz Ahmad, Ayoub Rashid Ch, Muhammad Saqlain Tahir
  Chromatographia.2020; 83(12): 1453.     CrossRef
• Cardiorenal protection with SGLT2: Lessons from the cardiovascular outcome trials
  José Silva‐Cardoso, Omar Sheikh, Mouhamed Nashawi, Son Pham, Kelly M. Gallegos, Laith R. Dinkha, Robert J. Chilton
  Journal of Diabetes.2020; 12(4): 279.     CrossRef
• Effect of the Sodium-Glucose Cotransporter 2 Inhibitor, Dapagliflozin, on Genitourinary Infection in an Animal Model of Type 2 Diabetes
  Jin Bong Choi, Je Mo Yoo, Ye-Jee Lee, Jae Woong Kim, Seung-Ju Lee, Hee Youn Kim, Dong Sup Lee, Seung-Hyun Ko, Hyun-Sop Choe
  International Neurourology Journal.2020; 24(1): 21.     CrossRef
• Sodium‐glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter‐organ crosstalk
  Jin Hee Kim, Minyoung Lee, Soo Hyun Kim, So Ra Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Jin Won Cho, Yong‐ho Lee
  Diabetes, Obesity and Metabolism.2019; 21(4): 801.     CrossRef
• Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Jae Hyun Bae, Eun-Gee Park, Sunhee Kim, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim
  Scientific Reports.2019;[Epub]     CrossRef
• SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
  Chenguang Li, Jie Zhang, Mei Xue, Xiaoyu Li, Fei Han, Xiangyang Liu, Linxin Xu, Yunhong Lu, Ying Cheng, Ting Li, Xiaochen Yu, Bei Sun, Liming Chen
  Cardiovascular Diabetology.2019;[Epub]     CrossRef
• An update of SGLT1 and SGLT2 inhibitors in early phase diabetes-type 2 clinical trials
  Ernest Adeghate, Sahar Mohsin, Faisal Adi, Fares Ahmed, Ali Yahya, Huba Kalász, Kornelia Tekes, Ernest A. Adeghate
  Expert Opinion on Investigational Drugs.2019; 28(9): 811.     CrossRef
• Stability‐indicating chromatographic and chemometric methods for environmentally benign determination of canagliflozin and its major degradation product; A comparative study and greenness assessment
  Aml A. Emam, Nada S. Abdelwahab
  Biomedical Chromatography.2019;[Epub]     CrossRef
• A Lower Baseline Urinary Glucose Excretion Predicts a Better Response to the Sodium Glucose Cotransporter 2 Inhibitor
  You-Cheol Hwang, Jae Hyeon Kim, Byung-Wan Lee, Woo Je Lee
  Diabetes & Metabolism Journal.2019; 43(6): 898.     CrossRef
• Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
  Ji-Yeon Lee, Yongin Cho, Minyoung Lee, You Jin Kim, Yong-ho Lee, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
  Diabetes & Metabolism Journal.2019; 43(2): 158.     CrossRef
• Comparative Efficacy and Safety Among Sodium-glucose Cotransporter-2 Inhibitors in Type 2 Diabetes – Results from a Retrospective Single-centre Study
  Manash P Baruah, Sanjay Kalra
  European Endocrinology.2019; 15(2): 113.     CrossRef
• Canagliflozin stability study and ecofriendly chromatographic determination of its degradation product: A comparative study
  Aml A. Emam
  Journal of Separation Science.2018; 41(4): 822.     CrossRef
• Efficacy and tolerability of novel triple combination therapy in drug-naïve patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial
  Nam Hoon Kim, Soo Lim, Soo Heon Kwak, Min Kyong Moon, Jun Sung Moon, Yong-ho Lee, Ho Chan Cho, Juneyoung Lee, Sin Gon Kim
  BMJ Open.2018; 8(9): e022448.     CrossRef
• Short-term outcomes of patients with Type 2 diabetes mellitus treated with canagliflozin compared with sitagliptin in a real-world setting
  YL Shao, KH Yee, SK, Koh, YF Wong, LY Yeoh, S Low, CF Sum
  Singapore Medical Journal.2018; 59(5): 251.     CrossRef
• Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors
  Soo Lim, Robert H. Eckel, Kwang Kon Koh
  Atherosclerosis.2018; 272: 33.     CrossRef
• Effect of Empagliflozin, a Selective Sodium-Glucose Cotransporter 2 Inhibitor, on Kidney and Peripheral Nerves in Streptozotocin-Induced Diabetic Rats
  Kyung Ae Lee, Heung Yong Jin, Na Young Lee, Yu Ji Kim, Tae Sun Park
  Diabetes & Metabolism Journal.2018; 42(4): 338.     CrossRef
• The effect of Ramadan fasting and continuing sodium-glucose co-transporter-2 (SGLT2) inhibitor use on ketonemia, blood pressure and renal function in Muslim patients with type 2 diabetes
  Yanli Shao, Gwyneth Joy Lim, Chin Lian Chua, Yip Fong Wong, Ester Chai Kheng Yeoh, Serena Kiat Mun Low, Chee Fang Sum
  Diabetes Research and Clinical Practice.2018; 142: 85.     CrossRef
• Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease
  Dug-Hyun Choi, Chan-Hee Jung, Ji-Oh Mok, Chul-Hee Kim, Sung-Koo Kang, Bo-Yeon Kim
  Endocrinology and Metabolism.2018; 33(3): 387.     CrossRef
• Comparison between sodium–glucose cotransporter 2 inhibitors and pioglitazone as additions to insulin therapy in type 2 diabetes patients: A systematic review with an indirect comparison meta‐analysis
  Yun Kyung Cho, Ye‐Jee Kim, Yu Mi Kang, Seung Eun Lee, Joong‐Yeol Park, Woo Je Lee, Chang Hee Jung
  Journal of Diabetes Investigation.2018; 9(4): 882.     CrossRef
• Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea
  Eugene Han, Ari Kim, Sung Jae Lee, Je-Yon Kim, Jae Hyeon Kim, Woo Je Lee, Byung-Wan Lee
  Diabetes Therapy.2018; 9(4): 1689.     CrossRef
• Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus
  Eugene Han, Eugene Shin, Gyuri Kim, Ji-Yeon Lee, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• Clinical parameters affecting dapagliflozin response in patients with type 2 diabetes
  J.-Y. Lee, G. Kim, S.R. Kim, Y.-H. Lee, B.-W. Lee, B.-S. Cha, E.S. Kang
  Diabetes & Metabolism.2017; 43(2): 191.     CrossRef
• Glucagon and glucagon-like peptide-1 as novel anti-inflammatory and immunomodulatory compounds
  Daniella B.R. Insuela, Vinicius F. Carvalho
  European Journal of Pharmacology.2017; 812: 64.     CrossRef
• Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J‐STEP/INS): Results of a 16‐week randomized, double‐blind, placebo‐controlled multicentre trial
  Yasuo Terauchi, Masahiro Tamura, Masayuki Senda, Ryoji Gunji, Kohei Kaku
  Diabetes, Obesity and Metabolism.2017; 19(10): 1397.     CrossRef
• A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes
  Seon-Ah Cha, Yong-Moon Park, Jae-Seung Yun, Tae-Seok Lim, Ki-Ho Song, Ki-Dong Yoo, Yu-Bae Ahn, Seung-Hyun Ko
  Lipids in Health and Disease.2017;[Epub]     CrossRef
• Morning Spot Urine Glucose-to-Creatinine Ratios Predict Overnight Urinary Glucose Excretion in Patients With Type 2 Diabetes
  So Ra Kim, Yong-ho Lee, Sang-Guk Lee, Sun Hee Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Jeong-Ho Kim, Byung-Wan Lee
  Annals of Laboratory Medicine.2017; 37(1): 9.     CrossRef
• The Relationship between Increases in Morning Spot Urinary Glucose Excretion and Decreases in HbA1C in Patients with Type 2 Diabetes After Taking an SGLT2 Inhibitor: A Retrospective, Longitudinal Study
  So Ra Kim, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
  Diabetes Therapy.2017; 8(3): 601.     CrossRef
• Clinical and Genetic Features of Patients With Type 2 Diabetes and Renal Glycosuria
  Siqian Gong, Jiandong Guo, Xueyao Han, Meng Li, Lingli Zhou, Xiaoling Cai, Yu Zhu, Yingying Luo, Simin Zhang, Xianghai Zhou, Yumin Ma, Linong Ji
  The Journal of Clinical Endocrinology & Metabolism.2017; 102(5): 1548.     CrossRef
• Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
  Seok Joon Shin, Sungjin Chung, Soo Jung Kim, Eun-Mi Lee, Young-Hye Yoo, Ji-Won Kim, Yu-Bae Ahn, Eun-Sook Kim, Sung-Dae Moon, Myung-Jun Kim, Seung-Hyun Ko, Kwang-Hyun Baek
  PLOS ONE.2016; 11(11): e0165703.     CrossRef
• Sodium–glucose cotransporter 2 inhibitors: an evidence-based practice approach to their use in the natural history of type 2 diabetes
  Stanley S. Schwartz, Intekhab Ahmed
  Current Medical Research and Opinion.2016; 32(5): 907.     CrossRef
• Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes
  Fida Bacha, Sara Klinepeter Bartz
  Pediatric Diabetes.2016; 17(8): 545.     CrossRef
• Renal threshold for glucose reabsorption predicts diabetes improvement by sodium‐glucose cotransporter 2 inhibitor therapy
  Aya Osaki, Shuichi Okada, Tsugumichi Saito, Eijiro Yamada, Kumeo Ono, Yawara Niijima, Hiroto Hoshi, Masanobu Yamada
  Journal of Diabetes Investigation.2016; 7(5): 751.     CrossRef
• Sodium-glucose co-transporter inhibition in the treatment of diabetes: Sweetening the pot
  Carlos A Alvarez, Ian J Neeland, Darren K McGuire
  Diabetes and Vascular Disease Research.2015; 12(2): 74.     CrossRef
• A simple and sensitive high performance liquid chromatography assay with a fluorescence detector for determination of canagliflozin in human plasma
  Muzaffar Iqbal, Nasr Y. Khalil, Amer M. Alanazi, Khalid A. Al-Rashood
  Analytical Methods.2015; 7(7): 3028.     CrossRef
• Efficacy and safety of sodium–glucose cotransporter 2 inhibitors in type 2 diabetes: a meta-analysis of randomized controlled trials for 1 to 2 years
  Xiang-Yang Liu, Ning Zhang, Rui Chen, Jia-Guo Zhao, Pei Yu
  Journal of Diabetes and its Complications.2015; 29(8): 1295.     CrossRef
• Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin
  Arshpreet Kaur, Stephen J Winters
  Endocrinology, Diabetes & Metabolism Case Reports.2015;[Epub]     CrossRef
• Pharmacological treatment and therapeutic perspectives of metabolic syndrome
  Soo Lim, Robert H. Eckel
  Reviews in Endocrine and Metabolic Disorders.2014; 15(4): 329.     CrossRef

Citations

Citations to this article as recorded by  

• Association between lipids and apolipoproteins on type 2 diabetes risk; moderating effects of gender and polymorphisms; the ATTICA study
  Duane D. Mellor, Ekavi N. Georgousopoulou, Nathan M. D'Cunha, Nenad Naumovski, Christina Chrysohoou, Dimitrios Tousoulis, Christos Pitsavos, Demosthenes B. Panagiotakos
  Nutrition, Metabolism and Cardiovascular Diseases.2020; 30(5): 788.     CrossRef
• Effects of 7-Hydroxy-2-(4-hydroxy-3-methoxyphenyl)-chromen-4 -one from Swietenia macrophylla King Seed on Oxidized LDL, HOMA Beta and Glucagon like Peptide 1 (GLP-1) Gene Expression in Type 2 Diabetic Rats
  Prasetyastuti ., Sunarti ., Ahmad Hamim Sadewa, Sri Mursiti, Mustofa .
  Asian Journal of Biochemistry.2017; 12(3): 85.     CrossRef

Citations

Citations to this article as recorded by  

• Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
  Tadesse Asmamaw Dejenie, Endeshaw Chekol Abebe, Misganaw Asmamaw Mengstie, Mohammed Abdu Seid, Natnael Atnafu Gebeyehu, Getachew Asmare Adella, Gizchew Ambaw Kassie, Amanuel Yosef Gebrekidan, Molalegn Mesele Gesese, Kirubel Dagnaw Tegegne, Denekew Tenaw A
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Association between serum creatinine and type 2 diabetes in the Chinese population: a retrospective cohort study
  Rugang Li, Min He, Qilin Yang, Zezhi Liang, Ying li, Ling Huang, Rong Wu, Jieping Huang
  Scientific Reports.2023;[Epub]     CrossRef
• Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease
  Jaehyun Bae, Byung-Wan Lee
  Biomedicines.2023; 11(7): 1928.     CrossRef
• Reconsideration of the current models of estimated kidney function‐based drug dose adjustment in older adults: The role of biological age
  Radin Alikhani, Manjunath P. Pai
  Clinical and Translational Science.2023; 16(11): 2095.     CrossRef
• The Level of Plasma Cystatin C in Patients with Chronic Kidney Disease
  Tuan Nguyen Van, Linh Phan Ha, Diep Pham Thao, Minh Nguyen Thi Binh, Minh Hoang Thi, Thuan Huynh Quang, Lan Thi Phuong Dam
  Nephro-Urology Monthly.2022;[Epub]     CrossRef
• Role of cystatin C in urogenital malignancy
  Li Ding, Zijie Liu, Junqi Wang
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Comparison of cystatin C-based and creatinine-based glomerular filtration rate in the prediction of postoperative residual hypertension in aldosterone-producing adenoma patients after adrenalectomy
  Ching-Way Chen, Cheng-Hsuan Tsai, Chi-Sheng Hung, I-Jung Tsai, Yu-Wei Chiu, Chin-Cheng Chang, Kao-Lang Liu, Shih-Cheng Liao, Vin-Cent Wu, Yen-Hung Lin
  Clinica Chimica Acta.2021; 520: 147.     CrossRef
• Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
  Norbert H. Lameire, Adeera Levin, John A. Kellum, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer, Paul E. Stevens, Fergus J. Caskey, Chris K.T. Farmer, Alejandro Ferreiro Fuentes, Masafumi Fukagawa, Stuart L. Goldstein, Grace Igiraneza, Andreas Kr
  Kidney International.2021; 100(3): 516.     CrossRef
• Correlation of Serum Cystatin C with Renal Function in Gout Patients with Renal Injury
  Yanqun Wu, Shunhua Wang, Xiaoqing Xu
  Journal of Interferon & Cytokine Research.2021; 41(9): 329.     CrossRef
• Stressors and Resilience: An Integrative Model for Understanding Chronic Kidney Disease
  Jacob Hwang, Arvin Jenab
  Alternative and Complementary Therapies.2021; 27(6): 267.     CrossRef
• The role of serum cystatin C in estimation of renal function in survivors of critical illness
  Jirarat Eiamcharoenying, Win Kulvichit, Nuttha Lumlertgul, Tawatchai Chaiwatanarat, Sadudee Peerapornratana, Nattachai Srisawat
  Journal of Critical Care.2020; 59: 201.     CrossRef
• Clinician perspectives on inpatient cystatin C utilization: A qualitative case study at Mayo Clinic
  James Roland Markos, Karen S. Schaepe, Hilary R. Teaford, Andrew D. Rule, Kianoush B. Kashani, John C. Lieske, Erin F. Barreto, Pierre Delanaye
  PLOS ONE.2020; 15(12): e0243618.     CrossRef
• Influence of Anthropometric Measurements on Serum Creatinine, Urea and eGFR in Healthy Adolescent Subjects
  Kavita Rasalkar, Nagaraju Kashamsetty, Bandi Sai Karthik
  Journal of Evidence Based Medicine and Healthcare.2020; 7(36): 1917.     CrossRef
• Biology and Management of Navel Orangeworm (Lepidoptera: Pyralidae) in California
  Houston Wilson, Charles S Burks, Joshua E Reger, Jacob A Wenger, Kelly Tindall
  Journal of Integrated Pest Management.2020;[Epub]     CrossRef
• Low serum creatinine and risk of diabetes: The Japan Epidemiology Collaboration on Occupational Health Study
  Huanhuan Hu, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Hiroko Okazaki, Makoto Yamamoto, Toshiaki Miyamoto, Masafumi Eguchi, Takeshi Kochi, Makiko Shimizu, Taizo Murakami, Kentaro Tomita, Takayuki Ogasawara, Naoko Sasaki, Akihiko Uehara, Keisuke Kuwa
  Journal of Diabetes Investigation.2019; 10(5): 1209.     CrossRef
• Comparison of monitoring techniques in and near almonds and pistachios under mating disruption treatment for navel orangeworm
  C. Burks, B. Higbee, J. Beck
  Acta Horticulturae.2018; (1219): 331.     CrossRef
• Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients
  Caroline Pereira Domingueti, Rodrigo Bastos Fóscolo, Ana Cristina Simões e Silva, Luci Maria S. Dusse, Janice Sepúlveda Reis, Maria das Graças Carvalho, Ana Paula Fernandes, Karina Braga Gomes
  Archives of Endocrinology and Metabolism.2016; 60(2): 108.     CrossRef
• Diagnostic Accuracy of Serum Cystatin C for the Evaluation of Renal Dysfunction in Diabetic Patients: A Meta‐Analysis
  Shi‐kun Yang, Jun Liu, Xian‐ming Zhang, Chun Hu, Wei Zhang, Lin Sun, Hao Zhang
  Therapeutic Apheresis and Dialysis.2016; 20(6): 579.     CrossRef
• Treatable glomerular hyperfiltration in patients with active acromegaly
  Shingo Fujio, Koji Takano, Hiroshi Arimura, Mika Habu, Manoj Bohara, Horofumi Hirano, Ryosuke Hanaya, Yoshihiko Nishio, Chihaya Koriyama, Yasuyuki Kinoshita, Kazunori Arita
  European Journal of Endocrinology.2016; 175(4): 325.     CrossRef
• Glomerular filtration rate assessed by using creatinine and cystatin in patients treated with dabigatran
  Gianluca Gessoni, Sara Valverde, Francesca Gessoni, Letizia Valle, Marina Bortolotti, Vincenzo Lidestri, Michele Urso, Roberto Valle
  La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine.2016; 12(4): 243.     CrossRef
• СHARACTERISTICS OF THE HEART FATTY ACID-BINDING PROTEIN, INTERLEUKIN-6 AND INTERLEUKIN-8 AS ALTERNATIVE MARKERS OF DIABETIC NEPHROPATHY PROGRESSION IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
  Yu. A. Ryzhikova, I. N. Vorozhtsova, T. V. Saprina, V. D. Zavadovskaya, A. B. Merinov, I. V. Kulagina
  Bulletin of Siberian Medicine.2015; 14(5): 61.     CrossRef
• Performance of Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate Equations Depends on Patient Characteristics
  Jeffrey W Meeusen, Andrew D Rule, Nikolay Voskoboev, Nikola A Baumann, John C Lieske
  Clinical Chemistry.2015; 61(10): 1265.     CrossRef
• Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials
  Kristin M Corapi, Mary Anne Dooley, William F Pendergraft
  Arthritis Research & Therapy.2015;[Epub]     CrossRef
• Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
  Mahmoud Omar, Wael Abdel-Razek, Gamal Abo-Raia, Medhat Assem, Gasser El-Azab
  International Journal of Hepatology.2015; 2015: 1.     CrossRef
• Efficient expression, purification and characterization of native human cystatin C in Escherichia coli periplasm
  Yongjun Zhou, Yan Zhou, Jun Li, Jian Chen, Yuqin Yao, Lin Yu, Desheng Peng, Mingrong Wang, Dan Su, Yong He, Lantu Gou
  Protein Expression and Purification.2015; 111: 18.     CrossRef
• Comparison of Carvedilol and Metoprolol for Preventing Contrast-Induced Nephropathy after Coronary Angiography
  Mustafa Yılmaz, Alp Aydınalp, Kaan Okyay, Abdullah Tekin, Uğur Abbas Bal, Nilüfer Bayraktar, Aylin Yıldırır, Haldun Müderrisoğlu
  Cardiorenal Medicine.2015; 5(3): 199.     CrossRef

Citations

Citations to this article as recorded by  

• New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine
  Heng Yang, Gordon Sloan, Yingchun Ye, Shuo Wang, Bihan Duan, Solomon Tesfaye, Ling Gao
  Frontiers in Endocrinology.2020;[Epub]     CrossRef
• Patterns of Nerve Conduction Abnormalities in Patients with Type 2 Diabetes Mellitus According to the Clinical Phenotype Determined by the Current Perception Threshold
  Joong Hyun Park, Jong Chul Won
  Diabetes & Metabolism Journal.2018; 42(6): 519.     CrossRef
• Association between Pain Sensitivity, Central Sensitization, and Functional Disability in Adolescents With Joint Hypermobility
  Elizabeth A. Bettini, Ki Moore, Yunfei Wang, Pamela S. Hinds, Julia C. Finkel
  Journal of Pediatric Nursing.2018; 42: 34.     CrossRef
• The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes
  Vesna Dermanovic Dobrota, Pero Hrabac, Dinko Skegro, Ranko Smiljanic, Savko Dobrota, Ingrid Prkacin, Neva Brkljacic, Kristijan Peros, Martina Tomic, Vesna Lukinovic-Skudar, Vanja Basic Kes
  Health and Quality of Life Outcomes.2014;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• The protective effects of lipoxin A4 on type 2 diabetes mellitus: A Chinese prospective cohort study
  Sudan Wang, Xiaoyan Qian, Chao Shen, Qian Sun, Yang Jing, Bingyue Liu, Kexin Zhang, Mengyuan Li, Junrong Wang, Hui Zhou, Chen Dong
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Interaction between the GCKR rs1260326 variant and serum HDL cholesterol contributes to HOMA-β and ISIMatusda in the middle-aged T2D individuals
  Min Shen, Liying Jiang, Hechun Liu, Hao Dai, Hemin Jiang, Yu Qian, Zhixiao Wang, Shuai Zheng, Heng Chen, Tao Yang, Qi Fu, Kuanfeng Xu
  Journal of Human Genetics.2023; 68(12): 835.     CrossRef
• Elevated triglyceride/high-density lipoprotein-cholesterol ratio as a risk factor for progression to prediabetes: a 5-year retrospective cohort study in Japan
  Masanori Shimodaira, Yu Minemura, Tomohiro Nakayama
  Journal of Diabetes & Metabolic Disorders.2023;[Epub]     CrossRef
• Association ofTG/HDLCratio trajectory and risk of type 2 diabetes: A retrospective cohort study inChina
  Yanyan Zhang, Pei Qin, Yanmei Lou, Ping Zhao, Xue Li, Ranran Qie, Xiaoyan Wu, Minghui Han, Shengbing Huang, Yang Zhao, Dechen Liu, Yuying Wu, Yang Li, Xingjin Yang, Yang Zhao, Yifei Feng, Changyi Wang, Jianping Ma, Xiaolin Peng, Hongen Chen, Dan Zhao, Sha
  Journal of Diabetes.2021; 13(5): 402.     CrossRef
• Triglycerides/high-density lipoprotein cholesterol is a predictor similar to the triglyceride–glucose index for the diagnosis of metabolic syndrome using International Diabetes Federation criteria of insulin resistance in obese adolescents: a cross-sectio
  Nazlı Nur Aslan Çin, Hülya Yardımcı, Nevra Koç, Seyit Ahmet Uçaktürk, Mehtap Akçil Ok
  Journal of Pediatric Endocrinology and Metabolism.2020; 33(6): 777.     CrossRef
• Comparison of Serum PCSK9 Levels in Subjects with Normoglycemia, Impaired Fasting Glucose, and Impaired Glucose Tolerance
  Eugene Han, Nan Hee Cho, Seong-Su Moon, Hochan Cho
  Endocrinology and Metabolism.2020; 35(2): 480.     CrossRef
• Triglycerides/glucose index is a useful surrogate marker of insulin resistance among adolescents
  B Kang, Y Yang, E Y Lee, H K Yang, H-S Kim, S-Y Lim, J-H Lee, S-S Lee, B-K Suh, K-H Yoon
  International Journal of Obesity.2017; 41(5): 789.     CrossRef
• The TyG index may predict the development of cardiovascular events
  Laura Sánchez‐Íñigo, David Navarro‐González, Alejandro Fernández‐Montero, Juan Pastrana‐Delgado, Jose Alfredo Martínez
  European Journal of Clinical Investigation.2016; 46(2): 189.     CrossRef
• TyG Index Change Is More Determinant for Forecasting Type 2 Diabetes Onset Than Weight Gain
  David Navarro-González, Laura Sánchez-Íñigo, Alejandro Fernández-Montero, Juan Pastrana-Delgado, Jose Alfredo Martinez
  Medicine.2016; 95(19): e3646.     CrossRef
• Comparative analysis of the efficacy of omega-3 fatty acids for hypertriglyceridaemia management in Korea
  H.-S. Kim, H. Kim, Y. J. Jeong, S. J. Yang, S. J. Baik, H. Lee, S.-H. Lee, J. H. Cho, I.-Y. Choi, H. W. Yim, K.-H. Yoon
  Journal of Clinical Pharmacy and Therapeutics.2016; 41(5): 508.     CrossRef
• Relationship between insulin sensitivity and insulin secretion rate: not necessarily hyperbolic
  S. H. Kim, A. Silvers, J. Viren, G. M. Reaven
  Diabetic Medicine.2016; 33(7): 961.     CrossRef
• The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance but not of β cell function in a Chinese population with different glucose tolerance status
  Meicen Zhou, Lixin Zhu, Xiangli Cui, Linbo Feng, Xuefeng Zhao, Shuli He, Fan Ping, Wei Li, Yuxiu Li
  Lipids in Health and Disease.2016;[Epub]     CrossRef
• Interactive effects of C-reactive protein levels on the association between APOE variants and triglyceride levels in a Taiwanese population
  Semon Wu, Lung-An Hsu, Ming-Sheng Teng, Jeng-Feng Lin, Hsin-Hua Chou, Ming-Cheng Lee, Yi-Ming Wu, Cheng-Wen Su, Yu-Lin Ko
  Lipids in Health and Disease.2016;[Epub]     CrossRef
• Lipoproteins and β-Cell Functions: From Basic to Clinical Data
  Dae Ho Lee
  Diabetes & Metabolism Journal.2014; 38(4): 274.     CrossRef

Citations

Citations to this article as recorded by  

• Free-androgen Index in Women with Polycystic Ovarian Syndrome: A Meta-Analysis
  Prakash Patil, Neevan D'Souza, Sudeep D. Ghate, Lakshmi Nagendra, Harish B. Girijashankar
  Journal of Health and Allied Sciences NU.2023; 13(03): 380.     CrossRef
• Differential Association of FTO Gene variants and Haplotypes with the Susceptibility to Polycystic Ovary Syndrome According To Obesity in Women with PCOS
  Wassim Y. Almawi, Rita Nemr, Tomiris Atazhanova, Zainab H. Malalla, Sameh Sarray, Fekria E. Mustafa, Naeema A. Mahmood
  Reproductive Sciences.2023; 30(7): 2166.     CrossRef
• FTO: a critical role in obesity and obesity-related diseases
  Dan Yin, Yiyang Li, Xingyue Liao, Dewei Tian, Yunsi Xu, Cuilan Zhou, Jun Liu, Suyun Li, Jing Zhou, Yulin Nie, Hongqing Liao, Cuiying Peng
  British Journal of Nutrition.2023; 130(10): 1657.     CrossRef
• Association of FTO gene variant rs9939609 with polycystic ovary syndrome from Gujarat, India
  Hiral Chaudhary, Jalpa Patel, Nayan K. Jain, Sonal Panchal, Naresh Laddha, Rushikesh Joshi
  BMC Medical Genomics.2023;[Epub]     CrossRef
• ASSOCIATION BETWEEN FAT MASS AND OBESITY ASSOCIATED (FTO) RS17817449 GENE POLYMORPHISM WITH INSULIN RESISTANCE AND OBESITY IN THE PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
  Mahbobeh Moayeri, Masoumeh Nezhadali, Mahnaz Mohamadi
  Studies in Medical Sciences.2023; 33(12): 868.     CrossRef
• Association of FTO gene variants rs9939609 and rs1421085 with polycystic ovary syndrome
  Alaa A. Alnafjan, Afrah F. Alkhuriji, Hussah M. Alobaid, Zainb A. Babay, Mahmoud I. Khalil
  Egyptian Journal of Medical Human Genetics.2022;[Epub]     CrossRef
• Association of FTO gene variant rs9939609 with hyperandrogenemia and fasting glucose levels in South Indian women with polycystic ovarian syndrome
  Zeinab Naghshband, Suttur S. Malini
  Egyptian Journal of Medical Human Genetics.2022;[Epub]     CrossRef
• Metabolic and Molecular Mechanisms of Diet and Physical Exercise in the Management of Polycystic Ovarian Syndrome
  Giorgia Scarfò, Simona Daniele, Jonathan Fusi, Marco Gesi, Claudia Martini, Ferdinando Franzoni, Vito Cela, Paolo Giovanni Artini
  Biomedicines.2022; 10(6): 1305.     CrossRef
• Fat mass and Obesity Associated (FTO) gene and polycystic ovary syndrome: Insight into pathogenesis and association with insulin resistance
  Sadaf Parveen, Saba Khan, Haseeb Ahsan, Priyanka Thapa Manger, Bhavana Gupta, Roshan Alam
  Human Nutrition & Metabolism.2022; 30: 200174.     CrossRef
• Effect of green cardamom on the expression of genes implicated in obesity and diabetes among obese women with polycystic ovary syndrome: a double blind randomized controlled trial
  Sahar Cheshmeh, Negin Elahi, Maysa Ghayyem, Elaheh Mosaieby, Shima Moradi, Yahya Pasdar, Susan Tahmasebi, Mehdi Moradinazar
  Genes & Nutrition.2022;[Epub]     CrossRef
• In depth analysis of the association of FTO SNP (rs9939609) with the expression of classical phenotype of PCOS: a Sri Lankan study
  Umayal Branavan, Sulochana Wijesundera, Vishvanath Chandrasekaran, Carukshi Arambepola, Chandrika Wijeyaratne
  BMC Medical Genetics.2020;[Epub]     CrossRef
• Body Mass Index and Polycystic Ovary Syndrome: A 2-Sample Bidirectional Mendelian Randomization Study
  Yalin Zhao, Yuping Xu, Xiaomeng Wang, Lin Xu, Jianhua Chen, Chengwen Gao, Chuanhong Wu, Dun Pan, Qian Zhang, Juan Zhou, Ruirui Chen, Zhuo Wang, Han Zhao, Li You, Yunxia Cao, Zhiqiang Li, Yongyong Shi
  The Journal of Clinical Endocrinology & Metabolism.2020; 105(6): 1778.     CrossRef
• Polikistik Over Sendromu ve Obezite: FTO ve MC4R Gen Polimorfizmlerinin Rolü
  Ayçıl ÖZTURAN ŞİRİN, Yasemin AKDEVELİOĞLU
  Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi.2020; 4(3): 275.     CrossRef
• Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: a case control study
  Do Kyeong Song, Hyejin Lee, Young Sun Hong, Yeon-Ah Sung
  BMC Endocrine Disorders.2019;[Epub]     CrossRef
• Phenotype and genotype of polycystic ovary syndrome in Asia: Ethnic differences
  Jin Ju Kim, Young Min Choi
  Journal of Obstetrics and Gynaecology Research.2019; 45(12): 2330.     CrossRef
• Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis
  Ritu Deswal, Arun Yadav, Amita Suneja Dang
  Systems Biology in Reproductive Medicine.2018; 64(1): 12.     CrossRef
• Association between FTO gene polymorphisms and type 2 diabetes mellitus, serum levels of apelin and androgen hormones among Iranian obese women
  Farzaneh Ghafarian-Alipour, Shayan Ziaee, Mohamad Reza Ashoori, Mir Saeid Zakeri, Mohammad Ali Boroumand, Naser Aghamohammadzadeh, Maryam Abbasi-Majdi, Fatemeh Shool, Navid Sarakhs Asbaghi, Abolghasem Mohammadi, Nosratollah Zarghami
  Gene.2018; 641: 361.     CrossRef
• The role of FTO variants in the susceptibility of polycystic ovary syndrome and in vitro fertilization outcomes in Chinese women
  Ai Ling Liu, Hong Qing Liao, Jing Zhou, Yu Lin Nie, Cui Lan Zhou, Zhi Liang Li, Zi Fen Guo, Dong Xiu He, Yun Hua Zhu, Cui Ying Peng
  Gynecological Endocrinology.2018; 34(8): 719.     CrossRef
• Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis
  Joel Eriksson, Robin Haring, Niels Grarup, Liesbeth Vandenput, Henri Wallaschofski, Erik Lorentzen, Torben Hansen, Dan Mellström, Oluf Pedersen, Matthias Nauck, Mattias Lorentzon, Lise Lotte Nystrup Husemoen, Henry Völzke, Magnus Karlsson, Sebastian E. Ba
  PLOS ONE.2017; 12(4): e0176277.     CrossRef
• Post-transcriptional gene regulation by mRNA modifications
  Boxuan Simen Zhao, Ian A. Roundtree, Chuan He
  Nature Reviews Molecular Cell Biology.2017; 18(1): 31.     CrossRef
• The Role of Serum MicroRNA-6767-5p as a Biomarker for the Diagnosis of Polycystic Ovary Syndrome
  Do Kyeong Song, Yeon-Ah Sung, Hyejin Lee, Wan-Xi Yang
  PLOS ONE.2016; 11(9): e0163756.     CrossRef
• Haplotyping strategy highlights the specificity of FTO gene association with polycystic ovary syndrome in Tunisian women population
  Assila Ben Salem, Redha Attaoua, Nabil Mtiraoui, Sawssen Meddeb, Olfa Kacem, Mounir Ajina, Moncef Souissi, Patrick Poucheret, Christophe Normand, Touhami Mahjoub, Florin Grigorescu
  Gene.2015; 565(2): 166.     CrossRef
• FTO gene variants are not associated with polycystic ovary syndrome in women from Southern Brazil
  Ramon B. Ramos, Poli Mara Spritzer
  Gene.2015; 560(1): 25.     CrossRef
• Interaction between common variants of FTO and MC4R is associated with risk of PCOS
  Huiqin Yuan, Guoping Zhu, Fang Wang, Xiang Wang, Huihui Guo, Mo Shen
  Reproductive Biology and Endocrinology.2015;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Perioperative Glycemic Management in Cardiac Surgery: A Narrative Review
  Yada Thongsuk, Nian Chih Hwang
  Journal of Cardiothoracic and Vascular Anesthesia.2024; 38(1): 248.     CrossRef
• Ketone supplementation abolished isoflurane anesthesia-induced elevation in blood glucose level and increased recovery time from anesthesia in Wistar Albino Glaxo Rijswijk rats
  Zsolt Kovács, Dominic P. D’Agostino, Csilla Ari
  BMC Anesthesiology.2023;[Epub]     CrossRef
• Comparison of spinal versus general anesthesia on the perioperative blood glucose levels in patients undergoing lower abdominal and pelvic surgery: a prospective cohort study, Ethiopia
  Hirbo Samuel, Betelihem Girma, Mestawet Negash, Esubalew Muluneh
  Annals of Medicine & Surgery.2023; 85(4): 849.     CrossRef
• Impact of total intravenous anesthesia and total inhalation anesthesia as the anesthesia maintenance approaches on blood glucose level and postoperative complications in patients with type 2 diabetes mellitus: a double-blind, randomized controlled trial
  Xinghui Xiong, Yong He, Cheng Zhou, Qin Zheng, Chan Chen, Peng Liang
  BMC Anesthesiology.2023;[Epub]     CrossRef
• Epidural anesthesia as the component of postoperative analgesia in children
  Elmira A. Satvaldieva, Otabek Ya. Fayziev, Anvar S. Yusupov, Shaira A. Agzamova, Yakupdjan N. Fayziev
  Russian Pediatric Journal.2023; 26(3): 194.     CrossRef
• Influence of general anaesthesia on circulating biomarkers of glucose metabolism in pigs
  Berit Ø Christoffersen, Cathrine J Bundgaard, Karina R Hjøllund, Johannes Josef Fels, Kirstine K Boll, Mille K Lyhne, Lisbeth H Olsen
  Laboratory Animals.2023; 57(6): 650.     CrossRef
• A conformable microneedle sensor with photopatternable skin adhesive and gel electrolyte for continuous glucose monitoring
  Joohyuk Kang, Kyung Yeun Kim, Seungwan Kim, Hyejun Hong, Byeong-Soo Bae, Seung-Kyun Kang, Wonryung Lee
  Device.2023; 1(4): 100112.     CrossRef
• Intravital Ca2+ imaging of pancreatic β cell function after bariatric surgery
  Philip Tröster, Per-Olof Berggren
  Cell Calcium.2022; 104: 102566.     CrossRef
• Feasibility of Interstitial Fluid Ketone Monitoring with Microneedles
  Robert M. Taylor, Justin T. Baca
  Metabolites.2022; 12(5): 424.     CrossRef
• Use of a bio-electronic device comprising of targeted dual neuromodulation of the hepatic and celiac vagal branches demonstrated enhanced glycemic control in a type 2 diabetic rat model as well as in an Alloxan treated swine model
  Jonathan J. Waataja, Raj K. Nihalani, Chris N. Honda, Charles J. Billington
  Frontiers in Neuroscience.2022;[Epub]     CrossRef
• The influence of anesthesia type on perioperative maternal glycemic-stress response during elective cesarean section: A prospective cohort study
  Diab A. Bani Hani, Omar F. Altal, Adel Bataineh, Mahmoud Al Athamneh, Mohammad Altarawneh, Moath Alshawaqfeh, Hajar Haddouchane, Sultan M. Al-Zyoud, Musa'b Hamarsheh, Ala”a A. Alhowary
  Annals of Medicine and Surgery.2021; 64: 102209.     CrossRef
• Amelioration of Hippocampal Insulin Resistance Reduces Tau Hyperphosphorylation and Cognitive Decline Induced by Isoflurane in Mice
  Liangyu Peng, Xin Fang, Fangxia Xu, Shuai Liu, Yue Qian, Xiangdan Gong, Xin Zhao, Zhengliang Ma, Tianjiao Xia, Xiaoping Gu
  Frontiers in Aging Neuroscience.2021;[Epub]     CrossRef
• Propofol Improved Glucose Tolerance Associated with Increased FGF-21 and GLP-1 Production in Male Sprague-Dawley Rats
  Chih-Cheng Wu, Chih-Jen Hung, Ya-Yu Wang, Shih-Yi Lin, Wen-Ying Chen, Yu-Hsiang Kuan, Su-Lan Liao, Ching-Ping Yang, Chun-Jung Chen
  Molecules.2020; 25(14): 3229.     CrossRef
• Dexmedetomidine alleviates insulin resistance in hepatocytes by reducing endoplasmic reticulum stress
  Fanfan Liu, Shaojun Zhu, Lifeng Ni, Ling’er Huang, Kuirong Wang, Yanfeng Zhou
  Endocrine.2020; 67(1): 87.     CrossRef
• In vivo Ca 2+ dynamics in single pancreatic β cells
  Stefan Jacob, Martin Köhler, Philip Tröster, Montse Visa, Concha F. García‐Prieto, Tomas Alanentalo, Tilo Moede, Barbara Leibiger, Ingo B. Leibiger, Per‐Olof Berggren
  The FASEB Journal.2020; 34(1): 945.     CrossRef
• Isoflurane and Carbon Dioxide Elicit Similar Behavioral Responses in Rats
  Satyajit Kulkarni, Debra Hickman
  Animals.2020; 10(8): 1431.     CrossRef
• Effect of Spinal Anesthesia versus General Anesthesia on Blood Glucose Concentration in Patients Undergoing Elective Cesarean Section Surgery: A Prospective Comparative Study
  Khaled El-Radaideh, Ala’’a Alhowary, Mohammad Alsawalmeh, Ahmed Abokmael, Haitham Odat, Amer Sindiani
  Anesthesiology Research and Practice.2019; 2019: 1.     CrossRef
• Alteration of FDG uptake by performing novel object recognition task in a rat model of Traumatic Brain Injury
  Shalini Jaiswal, Nicole Hockenbury, Hongna Pan, Andrew Knutsen, Bernard J. Dardzinski, Kimberly R. Byrnes
  NeuroImage.2019; 188: 419.     CrossRef
• Comparison of sevoflurane and propofol anesthesia on the incidence of hyperglycemia in patients with type 2 diabetes undergoing lung surgery
  Hyuckgoo Kim, Jisoo Han, Sung Mee Jung, Sang-Jin Park, Nyeong Keon Kwon
  Yeungnam University Journal of Medicine.2018; 35(1): 54.     CrossRef
• In vivo measurement of the rate constant of liver handling of glucose and glucose uptake by insulin-dependent tissues, using a mathematical model for glucose homeostasis in diabetic rats
  Mercedes Lombarte, Maela Lupo, L. Fina Brenda, German Campetelli, A.R. Buzalaf Marilia, Marta Basualdo, Alfredo Rigalli
  Journal of Theoretical Biology.2018; 439: 205.     CrossRef
• Biomimetic electrospun coatings increase the in vivo sensitivity of implantable glucose biosensors
  Krishna Burugapalli, Shavini Wijesuriya, Ning Wang, Wenhui Song
  Journal of Biomedical Materials Research Part A.2018; 106(4): 1072.     CrossRef
• Sevoflurane Impairs Insulin Secretion and Tissue‐Specific Glucose Uptake In Vivo
  Kasper F. Høyer, Thomas S. Nielsen, Steve Risis, Jonas T. Treebak, Niels Jessen
  Basic & Clinical Pharmacology & Toxicology.2018; 123(6): 732.     CrossRef
• Metabolic response to three different diets in lean cats and cats predisposed to overweight
  Claudia Keller, Annette Liesegang, Diana Frey, Brigitta Wichert
  BMC Veterinary Research.2017;[Epub]     CrossRef
• Anaesthesia and changes in parameters that reflect glucose metabolism in pigs – a pilot study
  Elin Manell, Marianne Jensen-Waern, Patricia Hedenqvist
  Laboratory Animals.2017; 51(5): 509.     CrossRef
• Isoflurane and Sevoflurane Induce Severe Hepatic Insulin Resistance in a Canine Model
  Stella P. Kim, Josiane L. Broussard, Cathryn M. Kolka, Barbara Fam
  PLOS ONE.2016; 11(11): e0163275.     CrossRef
• Impact of benzodiazepines on brain FDG-PET quantification after single-dose and chronic administration in rats
  Jesús Silva-Rodríguez, Lara García-Varela, Esteban López-Arias, Inés Domínguez-Prado, Julia Cortés, Juan Pardo-Montero, Anxo Fernández-Ferreiro, Álvaro Ruibal, Tomás Sobrino, Pablo Aguiar
  Nuclear Medicine and Biology.2016; 43(12): 827.     CrossRef
• Effects of Glucose Load on Catabolism during Propofol-Based Anesthesia with Remifentanil in Patients with Diabetes Mellitus: A Prospective Randomized Trial
  Tomotsugu Yamada, Maiko Hasegawa-Moriyama, Mayumi Nakahara, Akira Matsunaga, Yuichi Kanmura
  Open Journal of Anesthesiology.2015; 05(09): 197.     CrossRef